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This thesis describes evaluation of a technique for
screening for the small-for-dates fetus using diagnostic
ultrasound. The studies were all performed in the Queen
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ABSTRACT
To minimise the hazards of fetal growth retardation by optimal
perinatal management, the small-for-dates fetus must be detected ante-
natally. However, because the detection rate during routine ante¬
natal care is usually less than 50 %, a technique for screening for
the small-for-dates fetus appears highly desirable. Diagnostic
ultrasound would appear the ideal tool for this.
A two-stage ultrasound examination schedule has been evaluated
as a procedure for screening for the small-for-dates fetus. The
first examination comprises accurate assessment of gestational age,
in early pregnancy, with which to interpret the results of the second
(assessment of fetal size) at the chosen screening period of between
34 and 36 weeks. To assess the best measurement at this latter
examination, seven different fetal parameters were measured, and
later compared, in a study of 474 largely unselected patients. Trunk
measurements were more effective than head measurements. Trunk area
and trunk circumference were very highly correlated (r = 0.995) and
were similarly effective. The product of two of the parameters, crown-
rump length and trunk area, (CRL X TA) which was found to have a
sensitivity of 94 % and a specificity of 88 %, was selected for further
study as the second-stage examination.
Prospective evaluation of 877 low risk and 201 high risk patients
confirmed the effectiveness of CRL X TA measurement with sensitivities
of 94 % and 92 % respectively. In all, 93 % of 122 single and 100 %
of 19 twin small-for-dates babies were detected in advance by CRL X TA
measurement. Analysis of pooled results confirmed better sensitivity
by CRL X TA compared with TA alone ( p < 0.001)
The two stage schedule is suitable as a screening technique because
it is simple, quick to perform and highly effective. A prospective
randomised controlled trial was performed on the 877 low risk patients
to assess the impact of screening. No advantage could be dempnstrated.
CRL x TA measurement is recommended in any patient in whom there is any
reason, however minor, to suspect that the fetus may be small-for-dates.
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In an address to the Edinburgh Obstetrical Society in 1902,
Ballantyne stated that "neither fetal size nor weight can be regarded
as sure indications of fetal age" (Ballantyne, 1902). Few others
possessed his insight and understanding and, for much of this century,
all babies of low birthweight have been classified as "premature", the
easily quantifiable index of weight being more attractive than the,
often uncertain, index of gestational age. However, writing in 1947*
McBurney states,
"Most obstetricians are able to recognise the 'presumptive
signs' of pregnancy. These findings accompanying a two month
period of amenorrhoea, should assure the physician of being
reasonably correct in diagnosing a pregnancy of six to eight
weeks duration. In such instances, when the patient has been
delivered of her baby within one or two weeks of, or even after
the estimated date of parturition, it is extremely annoying to
have a paediatrician insist that the baby is premature because
it may weigh only four and one-half or five pounds."
He went on to state that such babies were malnourished in utero and
that this might be due to a small placenta or to disturbance of the
placental circulation, and that the undernourishment might be suffi¬
ciently severe as to cause intrauterine death (McBurney, 1947).
Clifford, writing a few years later, classified the clinical features
associated with postmaturity; he included, amongst his case reports,
babies of low birthweight born after 300 days gestational age. The
associated findings of apparent recent weight loss and meconium
staining, he attributed to placental dysfunction (Clifford, 1954).
Further important studies, such as those of Warkany et al (1961) and
of Gruenwald (1963) which described, respectively, the clinical and
pathological features associated with retarded fetal growth, aided
wider appreciation of the differences between low birthweight preterm
infant and the low birthweight term infant.
As a result, accepted definitions have changed. Babies weighing
less than, or equal to, 2500 grams are classified as "low birthweight
infants" and not, as formerly "premature." Babies born after less
than 259 days (37 weeks) of pregnancy are defined as "pre-term
infants", those born between 259 and 293 days (37 to 41 weeks) as
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"term infants" and those born after 294 days (42 weeks) as "post-term
infants" (Ounsted and Cunsted, 1973)• Definitions of "light-for-dates
infants (also called "small-for-gestational age" or "small-for-dates")
vary according to different authors. These definitions include birth-
weight equal to or less than the 5th or 10th percentiles or minus 2
standard deviations below the mean for length of gestation according
to established birthweight charts (e.g. Lubchenco et al., 1963;
Thomson et al., 1968; Usher and McLean, 1969; Babson et al, 1970;
Milner and Richards, 1974). Around one-third of low birthweight
infants are not pre-term but are small-for-dates (Gruenwald, 1963)•
The term "dysmature", which has been used as synonymous with "small-
for-dates", is misleading and will not be used in this thesis. The
terms "intrauterine (or fetal) growth retardation" are more difficult
to define since they do not strictly speaking rely for classification
on quantifiable indices such as age or weight. This matter will be
discussed in detail later.
On reviewing the literature on factors which influence the rate
of fetal growth, it is apparent that many reports fail to distinguish
adequately between the pre-term and small-for-dates groups which con¬
stitute the low birthweight population. Some reports were published
before widespread acceptance of the new definitions, and others were
compiled in communities in which reliable information about gestational
age was unobtainable. Thus, many of the factors described in the
following discussion should be seen as possible, rather than definite,
influences on the rate of fetal growth.
ETHNIC FACTORS
Extensive data obtained in a World Health Organization study of
birthweight throughout the world, has shown that the average duration
of pregnancy in all cultures is constant (Rosa and Turshen, 1970).
Despite this, the variation in mean birthweight may be substantial.
Meredith (1970) reviewed more than 270 studies of birthweights which
were carried out between 1945 and 1966. The smallest neonates are
those of the Lumi tribe of New Guinea who inhabit the Toricelli
Mountains at an altitude of 1700 feet. Their babies have a mean
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birthweight of 2.40 kg (Wark and Malcolm 1969)* The largest babies
are born on the Carribean Islands of Nevis and Anguilla, where the
mean birthweight is 3.88 kg (Ashcroft et al., 1966). Almost as heavy-
are the infants of the Cheyenne tribe of the USA: the mean birthweight
is 3-83 kg, compared with a mean of 3»52 kg for the Caucasian popula¬
tion of the USA (Meredith, 1970). It is difficult to separate socio¬
economic and ethnic factors in explaining cross-cultural variation in
birthweight. The Lumi people, for example, were completely isolated
from the outside world until after the second world war; they live a
primitive existence on a staple diet of sago and leaves, supplemented
occasionally by birds and rodents (Wark and Malcolm, 1969)• The
inhabitants of Nevis and Anguilla are predominantly of West African
origin, their ancestors having been transported to the West Indies
as slaves during the 17th and 18th centuries; the mean birthweight
amongst the islanders is 800g greater than that of the indigenous
population of West Africa (Meredith, 1970).
The relative importance of ethnic factors in influencing birthweight
variation is of relevance in Britain because of the now substantial
immigrant Asian population. Studies in London (Grundy et al., 1978)
and in Leicester (MacVicar, 1981) have demonstrated a difference of
300g in mean birthweight between Asian and white populations. However,
the influence of this on fetal risk is, as yet, uncertain (British
Medical Journal, 1978). Certainly in the Leicester series there was a
three-fold greater perinatal mortality rate amongst small-for-dates
Asian infants than their white counterparts using identical criteria
but different birthweight charts to define each group. (MacVicar,
1981).
ALTITUDE
Babies born at high altitude are of lower birthweight than those
born at sea-level. The mean birthweight in Lake county, Colorado,
at an altitude of 10,000 feet, is 2.66 kg (Lichty et al., 1957); this
is the lowest mean birthweight recorded in a Caucasian population and
it is virtually identical to the mean birthweight amongst Pygmies
(Meredith, 1970). The lowering of birthweight at altitude does not
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appear to be due to a higher incidence of pre-term delivery or of
congenital abnormality (Lichty et al., 1957)* and both body length
and head size of the neonates are reduced (Howard et al., 1957a).
Neither arterial oxygen saturation nor haematocrit levels in neonates
in Lake County, differed from accepted values at sea-level to indicate
chronic fetal hypoxia as the cause of reduced growth (Howard et al,,
1957b). Kruger and Arias-Stella (1970) likewise found reduced birth-
weight in babies born at Rio Pallanga, 15,000 feet up in the Peruvian
Andes. However, whilst mean birthweight was 544B less in Rio Pallanga
than in Lima, at sea-level, the mean placental weight at high altitude
was 60g greater, suggesting a compensatory mechanism adapted to the
hypoxic environment. Similar findings have been noted in sheep raised
at high altitude (Alexander, 1978). Sobrevilla et al. (1968) found
reduced mean birthweight in a small group of infants delivered at an
altitude of 13,000 feet in the Andes, although they also noted
reduced placental weight. These authors also found oestriol excretion
to be reduced in pregnancy at high altitude despite good fetal outcome.
Small term babies born at high altitude show the same signs of
behavioural immaturity in interactive and motor abilities as do small-
for-dates neonates born at sea-level (Saco-Follitt, 1981). It should
be noted in passing that the widely-used birthweight chart of
Lubchenco et al. (1963) was compiled from data obtained in Denver,
Colorado, at an altitude of 5,000 feet above sea-level.
MATERNAL FACTORS
Mean birthweight is lower among babies born to mothers of lower
social class (Baird, 1963; Thomson et al., 1968; Rosa and Turshen,
1970). There is a large cluster of factors which may explain this,
including poor housing, nourishment and health, and maternal smoking.
To quote Ounsted and Ounsted (1973)s
"in a society such as our own, in which social class tends to
be inconsistant in a given biography, variable within a family
and markedly unstable over the generations, we think it a
doubtful measure in biological studies."
Larger mothers tend to have larger babies. Thomson et al. (1968)
found that the babies of women 170 cms tall and weighing 75 kgs will
be 750g heavier, on average, than those of women who are 150 cms tall
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and weigh 40 kg. Parity also influences the rate of fetal growth:
second and subsequent babies grow faster than first-born (Thomson et
al., 1968).
The relationship of maternal nutritional status to the rate of growth
of the fetus has been extensively studied. There is no clear evidence,
in developed countries, of improved outcome of pregnancy by dietary
supplementation (Rosa and Turshen, 1970). Beal (1971) studied a group
of white, middle class American women and found no significant correla¬
tion between carbohydrate, fat, protein or calorific intake during
pregnancy, and birthweight. Adverse fetal outcome was noted in a large
trial of high protein supplementation during pregnancy in New York
(Rush et al., 1980). Thomson (1957) and Baird (1963) have suggested
that the woman's life experience of nutrition is of more importance
to her reproductive capacity than dietary intake during pregnancy.
Studies carried out during times of war and in developing countries
have, however, indicated a relationship between maternal nutritional
status and fetal growth rate. The mean birthweight of Japanese infants
fell by 200g in the immediate post-war period, although there was no
change in mean gestational age (Gruenwald et al., 1967). There was a
similar fall in birthweight (240g) in Rotterdam and the Hague, between
September 1944 and May 1945, when a general strike resulted in wide¬
spread malnutrition (Smith, 1947). During the seige of Leningrad in
1941, half of all babies weighed less than 2.5 kg, this being
attributed to both pre-term delivery and fetal growth retardation
(Antonov, 1947). This was accompanied by a stillbirth rate of 5.6%
(unlike Holland where there was no increase in stillbirths). The
conditions in Leningrad were more extreme than in Holland and Antonov
stressed the probable additional influences of stress, physical
exertion and cold on poor reproductive outcome. Both Dutch and
Russian papers note prevalent amenorrhoea. Halbicht et al. (1974)
have reported increased birthweight by dietary supplementation of
pregnant women in poor Guatemalan villages where there is dietary,
biochemical and anthropometric evidence of protein deficiency. After
calorific supplementation was initiated there was a 40% decrease in
the incidence of low birthweight infants. This effect was not due to
a decrease in the rate of pre-term delivery.
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Exposure of the mother to various agents may result in inpairment
of fetal growth rate. The most widely recognised of these agents is
the cigarette (Lancet, 1979)» the mean birthweight of babies born to
smoking mothers being reduced by around 200g (Underwood et al., 1967;
Andrews and McGarry, 1972). It has been hypothesised that this effect
may be due to decreased nutritional intake in smoking mothers but this
was not confirmed by large studies in Canada (Meyer, 1978; Haworth et
al., 1980). The impairment of fetal growth rate is probably a direct
effect. Circulating carboxyhaemoglobin levels are higher in fetuses
of mothers who smoke, and this results in a shift to the left of the
oxygen dissociation curve with consequent reduced availability of
oxygen to fetal tissues (Cole et al., 1972). Other agents also appear
harmful. More than 30% of infants born to chronically alcoholic
mothers are small-for-dates (Jones et al., 1974). Stone et al. (1971)
reported on 382 pregnant heroin addicts. Almost half of their infants
were of low birthweight, 40% of these being born after 38 weeks.
Heroin is of low molecular weight and crosses the placenta and may,
itself,inhibit fetal growth although these mothers, like the alcoholics,
tend to show signs of multiple self deprivation and abuse. Prescribed
drugs have not been found blameless. Warrell and Taylor (1968) reported
a high incidence of small-for-dates infants born to mothers on corticos¬
teroid therapy throughout pregnancy, when compared with women with
similar illnesses but not taking steroid medication.
Maternal disease may also influence fetal growth rate. The best
recognised condition is hypertensive disease - both essential hyper¬
tension and pre-eclampsia. The 1958 British Perinatal Mortality Survey
found the increased incidence of small-for-dates infants to be confined
to those mothers with severe hypertensive disease (Butler and Alberman
1969). De Souza et al., (1976) found no lowering of mean birthweight
in pre-eclamptics, although Gruenwald (1966b) showed that while there
was a higher incidence of small-for-dates infants born to hypertensive
mothers, an excessive number of high birthweight infants resulted in
an approximation to the overall mean. Maternal diabetes mellitus,
whilst more characterically associated with excessive fetal growth,
may also impair intrauterine growth rate (Naeye, 1965; Gruenwald,
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1966b) when microangiopathy exists (Persson, 1974). In some parts of
the world, malaria may be implicated in reducing fetal growth; Cannon
(1958) showed that in 37% of cases in which the placenta showed signs
of malarial infection, the baby weighed less than 2.5 kg at birth. The
relative proportions of pre-term and small-for-dates infants were not
specified.
Following their experiments on crossing Shetland ponies and Shire
horses, Walton and Hammond (1958) proposed the concept of a maternal
regulator which determined fetal growth rate. This provided an
explanation for their findings that foals born to Shetland mares by
Shire stallions were of similar birthweight to pure Shetlands, and
that the foals of Shire mares by Shetland sires were similar in weight
to pedigree Shires. Ounsted and Ounsted (1966) have suggested that the
same mechanism exists in humans and that the rate of intrauterine growth
is principally determined, under physiological conditions, by two
factors : the pre-deteimined setting of the maternal regulator, and
antigenic dissimilarity between mother and fetus. The maternal
regulator, the nature of which is uncertain (Ounsted, 1965), would
account for the persistent production of small-for-dates infants by
some women who have no disease process to account for this. Extensive
pedigree studies have shown that this effect is transmitted through
women only (Ounsted and Ounsted, 1968). Evidence that antigenic
dissimilarity influences fetal growth rate has been provided by the
study of birthweight in mixed-sex multiple pregnancies (Ounsted and
Ounsted, 1970) on the assumption that the presence of the Y chromosome
in. a male fetus provides per se greater antigenic disparity with the
mother than if the fetus were female. This challenges the concept of
genetic (Cheek et al., 1977) or hormonal influences resulting in the
greater birthweight of male infants (Lubchenco et al., 1965? Thomson
et al., 1968; Usher and McLean, 1969; Babson et al., 1970; Milner
and Richards, 1974).
FETAL FACTORS
Various fetal anomalies are associated with low birthweight for
gestational age. Those include renal agenesis (Potter, 1965)» trisomy
18 (Warkany et al., 1964; Lubchenco, 1970), trisomy 21 (Lubchenco,1970),
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the de Lange syndrome (Silver, 1974), various forms of congenital
dwarfism (Black, 1961), osteogenesis imperfecta (Lubchenco, 1970) and
anencephaly, even allowing for the absence of skull and brain (Liggins,
1974). Naeye (1965b) has reported impaired fetal growth associated
with congenital cardiac malformations, the small size of these infants
being typified by reduced cell number in various organs; Davis (1967)
has shown reduced birthweight in infants with Fallot's tetralogy. In
contrast, Mehrizi and Drash (1961) found no essential difference in
birthweight between babies with both cyanotic and acyanotic congential
heart disease ana controls, except that infants with transposition of
the great vessels had a higher mean birthweight. The mechanism or
mechanisms by which intrauterine growth rate if reduced in association
with anomalous development is often uncertain and may vary with
different conditions. The cause of intrauterine death and fetal growth
retardation in renal agenesis is, for example, uncertain (Potter,1965);
the operation of bilateral nephrectomy on fetal lambs will impair
subsequent intrauterine growth without affecting plasma urea and
electrolyte concentrations (Thorburn, 1974). Reduced intrauterine
growth in anencephalics may be due to absence or deficiency of the
pituitary gland (biggins, 1974). It is generally accepted, however,
that in most cases of fetal abnormality, both anomalous development
and impaired growth are independant effects of a common cause. Spiers
(1982) has put forward the hypothesis that intrauterine growth
retardation predisposes the fetus to congenital malformation, but the
evidence for this is unconvincing.
Some prenatal infections may impair fetal growth, including rubella
(Naeye and Blanc, 1965; Lubchenco, 1970), syphilis, toxoplasmosis and
cytomegalic virus (Ounsted and Ounsted, 1973)• The most prominent of
these, rubella, is associated with reduced cell number in the affected
fetuses (Naeye and Blanc, 1965)•
The role of the fetal endocrine organs in regulating intrauterine
growth in the human is largely unclear. As has been discussed in the
context of anencephaly, absence or deficiency of the pituitary gland
appears to cause modest impairment of fetal growth. However, four
reported cases of isolated primary pituitary hypoplasia, or aplasia,
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related to babies of normal birthweight (Liggins, 1974). Babies with
either familial growth hormone deficiency or pituitary dwarfism with
high levels of inactive growth hormone, are usually of normal birth-
weight (Laron and Pertzelan, 1969)» as are infants with congenital
adrenal hypoplasia (Liggins, 1974). Thyroid hormone appears essential
for normal intrauterine growth in the sheep and Rhesus monkey, as has
been demonstrated by fetal thyroidectomy studies. Growth retardation
is not, however, generally evident in the athyroid human neonate;
there appea.rs to be inter-species differences in the ease with which
maternal thyroxine will cross the pla.centa (Thorburn, 1974). In con¬
trast to other hormones, insulin does seem to have an important role
in regulating growth of the human fetus. Hypoinsulinism resulting
from congenital diabetes mellitus leads to marked impairment of fetal
growth rate (Scott, 1966; Liggins, 1974).
Immunological factors may influence intrauterine growth (Scott,
1966). That greater antigenic dissimilarity with the mother may help
account for the greater birthweight of male infants (Ounsted and
Ounsted, 1970) has already been discussed. At least one tissue-
specific autoimmune disease (Grave's disease) may, when present in a
pregnant woman, be associated with impaired fetal growth (Jones,
1979). A proportion of those small-for-dates infants in whom there
is no apparent explanation for impaired intrauterine growth show
abnormal immunoglobulin profiles in their serum; whether this is
due to sub-clinical intrauterine infection or to a primary
immunological mechanism is uncertain (Jones, 1968).
MULTIPLE PREGNANCY
Babies born from multiple pregnancies tend to be smaller than
singleton neonates of similar gestational age. Gruenwald (1966a,
1974) has suggested that human fetal growth would follow a linea.r
path throughout the second and third trimesters of pregnancy were it
not for impairment of nutritional supply to the fetus. In reality,
departure from the hypothetical straight-line growth curve occurs at
varying gestational age depending on the population studied. This
flattening of growth rate occurs late in pregnancy in Sweden, for
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example, and earlier in less affluent countries; it occurs earlier
still in multiple pregnancies. Thus, in Birmingham, McKeown and
Record (1952) found that whilst deceleration of growth rate in
singleton pregnancies occurred at around 36 weeks, the same effect
was seen in twin pregnancies at about 30 weeks, and in triplet and
quadruplet pregnancies at 27 and 26 weeks respectively. Birthweight
studies of twins in other populations have shown similar findings,
with deceleration of growth rate occurring at between 29 and 33
»
weeks (Gruenwald, 1966b; Naeye et al., 1966; Daw and Walker, 1975;
Bleker et al., 1979). The clinical significance of this phenomenon
will be discussed in Chapter 6.
UTERO-PLACENTAL INSUFFICIENCY
Placental weight correlates well with infant birthweight, and this
has led to the suggestion that the size of the placenta determines
the growth rate of the fetus. This is unlikely to be true as it would
imply that the placenta normally functions near the limits of its
capacity, and there is no reason to think this; after all, a fetus
may survive after 50p/° of the placental surface area has separated from
the uterine wall with placental abruption. Both the fetus and placenta
are components of the conceptus and it is more likely that the growth
of both are regulated by the same mechanisms, or that the fetus regulates
the size of the placenta as it does the growth of its internal organs
(Gruenwald, 1974). Some workers have found an increased incidence of
impaired fetal growth associated with placenta praevia (Varma, 1972;
lleri et al., 1980), perhaps due to the unfavourable site of implantation
or due to fibrosis following repeated bleeding episodes. Others have
not found this association (e.g. Gabert, 1971). There have been claims
that marginal and velamentous insertion of the umbilical cord may
predispose to poor fetal growth, but this has not been demonstrated in
recent studies (Uyanwah-Akpom and Fox, 1977; Woods and Malan, 1978).
Placental infarction limits the area available for transfer between
fetal and maternal circulations, but infarction results from changes
in maternal blood vessels which supply the placental bed and it is not
an example of primary pathology of the placenta. There is, at present,
little to suggest that primary impairment of placental exchange
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mechanisms is an important cause of retarded fetal growth (Cheek et
al., 1977); of more importance seems to be the adequacy of the
maternal blood flow to the placental intervillous space. For these
reasons, the term "utero-placental insufficiency" is preferred to
"placental insufficiency." Severe utero-placental insufficiency
results in impaired transfer of oxygen, as well as nutrients, to the
fetus, with consequent fetal asphyxia and death; when less severe,
fetal growth will be restricted (Parer, 1976). This probably results
from the lack of nutrition per se, but an alternative hypothesis is
that an unknown placental-fetal factor causes impaired growth as a com¬
pensatory mechanism because unrestricted fetal growth in the presence
of compromised utero-placental blood flow would lead to accelerated
exhaustion of available oxygen and nutrients with the risk of fetal
death (Vorherr, 1982).
In animal experiments it is possible to reduce maternal blood flow
to the placenta by a variety of techniques (Dawes, 1976). Wigglesworth
(1964), for example, ligated the blood vessels of one uterine horn in
pregnant rats. Many of the conceptuses in the experimental horns died
after the operation and the surviving fetuses showed varying degrees of
stunting. There were differences in the degree of growth retardation
of different organs in the survivors, the growth of the liver being more,
and that of the brain less, retarded than the body as a whole - this is
similar to the pathological findings demonstrated in human small-for-
dates infants and will be discussed further on page 47. Sheppard and
Bonnar (1976) studied the ultrastructure of the arterial supply of the
human placenta in cases of severe fetal growth retardation and found
occlusive atheromatous lesions with considerable fibrin deposition in all
cases, whether or not the pregnancies had been complica.ted by maternal
hypertension. This would account for reduced blood flow to the intervillous
space. However, other workers (Brosens et al., 1977; Be Wolf et al.,
1980) have found these changes to be uncommon when fetal growth retarda¬
tion has not been associated with overt maternal vascular disease.
It has been postulated that the balance between the effects of the
prostanoids, prostacyclin and thromboxane A2, may serve as an important
physiological mechanism in the local control of regional, including
utero-placental, blood flow. Thromboxane A2 stimulates platelet
aggregation and causes vasoconstriction, and its production by
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activated platelets is enhanced in normotensive and hypertensive
pregnancies associated with retarded fetal growth (Wallenburg and
Rotmans, 1982). Prostacyclin, in contrast, is a strong vasodilator
and the most potent inhibitor of platelet aggregation known.
Production of prostacyclin by trophoblast is decreased in cases of
fetal growth retardation (Jogee et al., 1985). These two effects,
acting together, may account for the increased tendency to platelet
aggregation in spiral arteries (Sheppard and Bonnar, 1981) and the
decreased platelet lifespan (Wallenburg and Van Kessel, 1979)
observed in such pregnancies. There is no evidence of disseminated,
rather than local, intravascular coagulation in pregnancies complicated
by fetal growth retardation in the absence of severe pre-eclampsia
(Howie et al, 1971; Elder and Myatt, 1976). Other haematological
and haemorheologica.l features have been described in pregnancies
which result in a small-for-dates infant. These include reduced
plasma volume (Hytten and Paintin, 1963; Arias, 1975) and increased
blood viscosity due to decreased erythrocyte deformability (Thorburn
et al., 1982).
Whilst more knowledge is being gained about the pathophysiology
of utero-placental insufficiency, the cause, in the absence of
maternal vascular disease, is unknown.








In the preceding discussion, the many factors which can influence
intrauterine growth rate and thus lead to the delivery of a small-for-
dates infant have been described. Such infants are, as a group, more
at risk of certain perinatal problems than are those that are
appropriately grown, although the risks applicable to the individual
small-for-dates fetus vary in degree and nature according to the
aetiological background. While the high risk status of the small-for-
dates group is substantiated by many publications there is no
universally accepted definition of what constitutes a small-for-dates
infant and, still less, of what constitutes fetal growth retardation.
Definition of small-for-dates (or more accurately light-for-dates*)
relies on reference to a chart which plots birthweight against
gestational age at delivery. Various such charts have been compiled.
One of the earliest, and probably the most widely used, was constructed
in Denver, Colorado, from the birthweight data of 5>635 liveborn infants
(Lubchenco et al., 1963). The 10th percentile curve was used to
differentiate small-for-dates from appropriately grown infants (Battaglia
and Lubchenco, 1967). Thomson and colleagues published, in 1968, the
results of a study of the birthweight of 52,000 singleton infants in
Aberdeen (Thomson et al., 1968). Careful attention was paid to assess¬
ment of gestational age and this chart has been widely used in the
United Kingdom and elsewhere, and extensively used in obstetric ultra¬
sound research; both the 5th and 10th percentiles have been used as
demarcation lines, and the Aberdeen chart also permits allowance for
the effects of sex and parity in influencing birthweight. Usher and
McLean (1969) have compiled a chart based on Montreal births; these
authors advocate the more stringent definition of small-for-dates as
birthweight below minus 2 standard deviations from the mean. Many other
charts have been compiled and details vary with the populations studied.
To correspond to conventional obstetric terminology in the United
Kingdom, the term "small-for-dates" is used in this thesis.
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The risk of perinatal damage to small-for-dates fetuses will likewise
vary according to the definition employed.
There are, however, limitations in defining impaired intrauterine
growth in terms of birthweight for gestational age. Some fetuses may
cease to grow at a sufficiently late stage in pregnancy that their
subsequent birthweight is not so low as to include them in the small-
for-dates category although they have clearly failed to achieve their
genetic growth potential. Miller and Hassanein (1971), in response
to this problem, have attempted to improve detection of impaired
intrauterine growth by measurement of the dimensions of the newborn
to assess nutritional status by calculation of the Ponderal index.
Turner (1971) used a novel approach in comparing birthweights of
infants with those of their siblings. She found normal variation in
birthweight within sibship to be in the order of 1 10%. Study of
infants with rubella embryopathy showed that 80% had birthweights
outside this range although only about half of these would have been
classified as small-for-dates by conventional standards. This
approach, obviously applicable only to the offspring of multiparous
mothers, could be used more widely to study impaired fetal growth
due to utero-placental insufficiency although the fact that this
problem tends to be recurrent would pose some difficulty.
Certainly it is unclear what is the clinical significance of impaired
fetal growth which either occurs so late in pregnancy or is of such a
mild degree as not to "deflect" the fetus into the small-for-dates
zone.
In the following discussion of the risks of fetal growth
retardation, attention centres on the outcome for small-for-dates
fetuses.
PERINATAL MORTALITY
Perinatal (especially intrauterine) death is an important risk of
being small-for-dates. The Scottish Perinatal Mortality Survey for
1977, which assessed all perinatal deaths in the country during that
year, showed that 116 deaths in singleton pregnancies (11%) occurred
in small-for-dates babies in the absence of fetal abnormality, maternal
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disease and other complications of pregnancy (Mcllwaine et al., 1969b);
80% of these deaths occurred in utero. A study in Melbourne of 500
consecutive small-for-dates babies likewise demonstrated a raised
perinatal mortality rate : 5.2% compared with 1.2% in appropriately
grown controls (Dobson et al., 1981). The perinatal mortality rate
was 8.5 times greater in those infants whose birthweight was less than
the 5th percentile for gestational age than those whose birthweight
fell between 5th and 10th percentiles (19% against 2.2%); this was in
part due to an increased incidence of major abnormality in the very
small babies. Lugo and Cassidy (1971), in Alabama, found that, when
babies of birthweight less than 1 kg are excluded, the perinatal
mortality rate among small-for-dates babies (almost 10%) is equiva¬
lent to that of pre-term infants. In a review of perinatal mortality
in Montreal, Usher (1971) found the mean gestational age at the time
of intrauterine death among small-for-dates fetuses to be 57 weeks
with all deaths occurring after 32 weeks; he felt that most of the
deaths were potentially preventable by early recognition of fetal
growth retardation and planned early delivery. Similarly, the
Scottish Perinatal Mortality Survey demonstrated that 45% of
intrauterine deaths among small-for-dates fetuses occurred after the
36th week (Mcllwaine et al., 1979b). Death is usually due to
asphyxia resulting from utero-placental insufficiency, although
fetal malformation also makes a significant contribution.
PERINATAL ASPHYXIA
There are two main reasons why perinatal asphyxia, is more common
among small-for-dates fetuses : firstly, uterine contractions exacer¬
bate the utero-placental insufficiency and secondly, as a consequence
of intrauterine malnutrition, the small-for-dates fetus has less
metabolic reserve to withstand the hypoxic stress of labour. In
addition, the umbilical vessels may be more vulnerable to compression
during labour because the amniotic fluid volume is often reduced and
Wharton's jelly decreased in amount. Low et al., (1972) found that
almost half of the small-for-dates fetuses in their series had moderate
or severe metabolic acidosis at delivery; intrapartum asphyxia was
more common when labour was pre-term (83% incidence). Perry et al.,
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(1976) also found an increased incidence of low Apgar scores among
small-for-dates fetuses, with a higher incidence after pre-term than
term labour. Dobson et al., (19B1) quoted a 13% incidence of fetal
asphyxia (defined as an Apgar score of less than 5 at one minute)
among small-for-dates infants with birthweights less than the 5th
percentile; both those with birthweights between 5th and 10th
percentiles and normally grown controls had a 7% incidence of fetal
asphyxia. Lin et al., (1980) studied 37 small-for-dates and 108
appropriately grown fetuses during labour. In the absence of
decelerations on continuous fetal heart rate tracings there was no
difference in acid-base status between the two groups. Late
decelerations were, however, more common in the small-for-dates
group (30% incidence compared to 7% in controls). Small-for-dates
fetuses that did develop heart rate decelerations were more likely
to develop lactic acidosis than were normally grown babies,
indicating diminished metabolic reserve.
NEONATAL PROBLEMS
Neonatal morbidity encountered by small-for-dates infants may
conveniently be divided into three categories:
(i) related to fetal factors, such as chromosomal abnormalities,
congenital infections and other malformations;
(ii) related to intrapartum asphyxia, such as meconium aspiration
syndrome, hyperviscosity and post-asphyxia encephalopathy;
(iii) related to abnormalities of substrate transfer and
aberrations of hormonal control, such as neonatal
hypoglycaemia and hypocalcaemia. (Oh, 1977).
Neonatal hypoglycaemia is of particular interest because it is not
uncommon, it is easily treated if recognised (Neligen et al., 1963),
and it may account in part for the high prevalence of long term neuro¬
logical impairment noted in early studies of the postnatal development
of small-for-ds.tes infants. Hypoglycaemia results from the decreased
stores of glycogen which follow intrauterine malnutrition, and may be




Fetal malformation is not a consequence of intrauterine growth
retardation but it has a higher incidence among small-for-dates babies
and this has been discussed earlier in this chapter. In their series
Dobson et al., (1981) found an incidence of 17% of major malformation
among small-for-dates infants with birthweights less than the 5th
percentile.
LONG-TERM SEftUELAE
Reports on post-natal growth of small-for-dates infants have
described different findings. Fitzhardinge and Steven (1972a)
followed up 96 infants that were severely growth retarded at term,
until between 4 and 6 years of age. After initial catch-up growth,
from below the 3rd percentile at birth to between the 10th and 25th
percentiles at six months, the mean height and weight of the group
remained in the same low percentile band. A more recent study of
postnatal growth of 47 small-for-dates infants (Davies and Beverley,
1979) showed no significant difference from normal birthweight
controls when assessed at 12 months of age. Post-natal growth of
small-for-dates infants will be discussed further in Chapter 2.
The effects of fetal growth retardation on ultimate neorological
and intellectual competence are obviously of considerable importance
Animal experiments have shown that the developing brain is most
vulnerable to the effects of malnutrition at the time of its fastest
growth (Dobbing and Sands, 1970)• This brain growth spurt runs from
about mid-pregnancy to about 18 months of postnatal age in the human
(Dobbing, 1974)* Dobbing has predicted that when growth retardation
only occurs during the third trimester and is followed by good catch¬
up growth after delivery no very deleterious effect on final outcome
would be expected. This is not true if retarded growth has been
present from mid-pregnancy or if the small-for-dstes infant is
delivered into an environment lacking in nutrition or psychological
stimulation. Studies of long-term outcome of small-for-dates infants
have shown conflicting results. Early studies were retrospective and
evaluated outcome of small-for-dates babies born during the 1950's;
these reported mental deficiency to be common (Warkany et al., 1961;
Barker, 1966). Drillien (1970) found the mean IQ, to be lower in small-
for-dates infants raised in working class homes than in similar infants
born to middle class mothers.
The brain of small-for-dates babies may be damaged not only by the
direct effects of intrauterine malnutrition but also by such perinatal
factors as asphyxia and hypoglycaemia; their brains may be considered
"primed" for further damage (Pape and Fitzhardinge, 1981). Improved
perinatal care may thus diminish the incidence of brain damage, and
more recent studies have generally been more optimistic about outcome
although disagreement continues to exist. Thus, Babson and Kangas
(1969) found no difference in IQ scores at 4 years of age between
small-for-dates infants and normal birthweight controls. Vohr et al.,
(1978) showed that pre-term small-for-dates infants had similar
developmental testing results at 2 years of age, to those in
appropriately grown pre-term controls of similar birthweight. On the
other hand, behavioural and motor differences have been noted in small-
for-dates neonates by Michaelis et al. (1970) and by Low et al. (1978);
in their preliminary findings of a prospective study of outcome in 88
small-for-dates infants the latter authors noted significant differences
in developmental indices assessed at 12 months of age and compared with
controls. Fitzhardinge and Steven (1972b), in their follow-up study of
small-for-dates infants, found major neurological problems to be rare
but minimal cerebral dysfunction, speech defects and poor school per¬
formance to be common despite normal mean IQ. Gross et al. (1978)
found that small head circumference and abnormal neurological findings
in small-for-dates infants in the newborn period were associated with
later neurological deficit.
There is some evidence that antenatal identification of the small-
for-dates fetus with subsequent optimal management may improve long-
term intellectual outcome (Rhodes, 1973)*








As has been discussed, there are a large variety of reasons why an
individual fetus may be small-for-dates; the degree and type of risk
which that fetus faces also varies widely. Although assessment of the
wellbeing of the growth retarded fetus will not be discussed until the
next section, it may be stated now that the risks of intrauterine death
and perinatal asphyxia can, to a large extent, be predicted by certain
biophysical tests. However, in the absence of other pregnancy compli¬
cations, the fetus must be identified antenatally as small-for-dates
before these forms of assessment are implemented. This section will
consider the different techniques and strategies which have been
advocated to aid detection of the small-for-dates fetus; ultrasound
techniques will not be described here but are discussed in detail in
Chapter 2.
CLINICAL ASSESSMENT
Abdominal palpation has been the main method with which to identify
the small-for-dates baby antenatally. The size of the fetus is judged
and compared to that expected at the given gestational age. Repeated
palpation by the same obstetrician over a period of time may indicate
a failure of growth of the fetus, and clinical examination may give an
impression of oligohydramnios to provide further evidence of growth
retardation. However, abdominal palpation is not precise, and varying
thickness of the maternal anterior abdominal wall and varying volumes
of amniotic fluid may distort perception of fetal size. In addition,
Loeffler (1967) reported that although prediction of birthweight by
abdominal palpation was satisfactory when the fetus was of average
size, its accuracy decreased at each extreme of the birthweight range.
He found that about 60% of predictions of babies weighing less than
2.3 kg at birth had been inaccurate by over 450 g. and in each case
the predicted birthweight had been overestimated. Most published
series have reported detection rates of small-for-dates fetuses by
abdominal palpation, during routine antenatal care, to range between
only 30% and 50% (Campbell 1974a; Hall et al., 1980; Rosenberg at al.,
1982a).
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Tape measurement of abdominal girth was not found to be of any value
by Elder et al. (1970) in detecting the small-for-dates fetus but there
has, recently, been renewed interest in tape measurement of symphsial-
fundal height. Using this, Westin (1977) described 68% detection of
small-for-dates fetuses with a false-positive rate of 11% in an
unselected series of 428 pregnancies, and Belizan et al. (1976) reported
86% detection with a false-positive rate of 10% in a study of 139
patients. Quaranta et al. (1981) in a retrospective study of 138 high
risk patients quoted a sensitivity of 73% in detection of small-for
dates fetuses with a false-positive rate of 21%. Rosenberg and
colleagues (1982b), however, studying fundal height measurement in a
larger series of 761 women during routine antenatal care found that
only 56% of small-for-dates fetuses were detected, with a false-positive
rate of 15%- Thus, while fundal height measurement is simple and
inexpensive and therefore particularly suitable for use in developing
countries (Belizan et al., 1978), its use in ordinary clinical practice
appears to leave many small-for-dates fetuses undetected.
Thomson and Billewicz (1957) described an increased incidence of low
birthweight babies born to mothers who gain little weight during
pregnancy. This was investigated further by Elder et al. (1970) who,
in a retrospective study, found mean weekly weight gain among mothers
who produced small-for-dates infants to be 0.78 lbs per week in
contrast to 0.86 lbs per week in normal controls - this difference
reaches statistical significance. These authors studied prospectively
841 apparently normal pregnant women and found the incidence of small-
for-dates babies was 5% when weight gain was normal, 16% when weight
was static and 15% when weight dropped. Whilst 77% of small-for-dates
babies were born to mothers with abnormal weight profiles, the
specificity and the predictive value of the technique were low, 50%
and 16% respectively. Mann et al. (1974) found no difference in
weight gain between pregnancies resulting in a small-for-dates fetus
(detected antenatally), those resulting in a small-for-dates fetus (not
detected antenatally) and those resulting in normally grown babies.
Gordon et al. (1978) found weight gain to be of no value in predicting
"fetal risk" (such risk including the delivery of a small-for-dates
fetus).
RISK ASSESSMENT
Additional strategies to aid detection of fetal growth retardation
have evolved. The main approach is to define a group of women at high
risk of producing a small-for-dates infant so that intensive antenatal
monitoring may be selectively implemented to identify those fetuses
that are, in fact, growth retarded and to guide subsequent management.
The criteria used to identify such high risk groups are based on
epidemiological factors, past reproductive performance, and the
occurrence during the current pregnancy of complications known to be
associated with growth retardation. There has not, however, always
been unanimity as to what maternal factors are associated with fetal
growth retardation (Fedrick and Adelstein, 1978). In a study of 182
women who produced small-for-dates infants Low and Galbraith (1974)
found that 18% had obstetric complications such as pre-eclampsia or
antepartum haemorrhage, 15% had had obstetric problems in a previous
pregnancy (including a previous small-for-dates infant), 18% had what
was termed pregnancy complications such as twins or postmaturity, and
8% had a significant maternal disease; 48% of these patients had no
high risk features. On analysing the 1958 British Perinatal Mortality
Survey data, Fedrick and Adelstein (1978) found that the risk of
bearing a small-for-dates infant correlates with pre-pregnancy weight,
maternal height, smoking, nulliparity, low social class, maternal
employment, previous small-for-dates infant, threatened abortion and
severe pre-eclampsia. From these data a scoring system was developed
to predict the risk of having a small-for-dates baby (Adelstein and
Fedrick, 1978). When it was applied, however, to 490 singleton
pregnancies the authors found that 20% of primigravidas would have
been identified as high risk but that only 8%. of this group were
actually delivered of small-for-dates infants, and that as many as 54%
of the small-for-dates babies in the primigravid group were born to
low risk mothers. Although the scoring system proved rather better in
parous patients it was concluded that this approach was not effective.
An evaluation of risk assessment in the Queen Mother's Hospital gave
broadly similar results which are described in Chapter
BIOCHEMICAL ALT) HAEMATOLOGICAL ASSESSMENT
Oestriol estimation has been used for many years as a means of
assessing fetal growth (Macnaughton, 19^7)• Whilst there is general
agreement that oestriol levels, in blood or urine, tend to be
depressed in the presence of retarded fetal growth, overlap with
results from normal pregnancies may be considerable (Tulchinsky,
1977). Thus, McFadyen et al. (198O) in a recent study found 10% of
urinary oestrogen results from small-for-dates pregnancies to be
above the mean for the whole population. There is a large literature
on the use of oestrogen assays in obstetrics and, in keeping with the
theme of this thesis, emphasis is placed on studies which have con¬
sidered the role of oestrogen assay as a screening procedure to
detect the small-for-dates fetus. This ha.s been recommended by such
authors as Beischer et al. (1968) who found 19 of 34 small-for-dates
fetuses to be associated with low urinary oestriol results. Barnard
and Logan (1972) evaluated urinary oestriol as a screening tool and
found that, at 31 weeks, 70% of normally grown babies would have to
be incorrectly identified as possibly growth retarded to allow
detection of 95% of small-for-dates fetuses. Nielsen (1983) found
19% of small-for-dates babies to be identified by low serum oestriol
levels. Duenholter et al. (1975) conducted a prospective randomised
controlled trial of plasma oestriol estimation in high risk
pregnancies and found no beneficial effect on fetal outcome. Wilde
and Oakey (1975) have reviewed the relevant literature and concluded
that oestrogen estimation is of little value in the diagnosis of
retarded fetal growth. This should be distinguished from the possible
value of oestrogen estimation to assess feto-placental function after
the diagnosis of fetal growth retardation has been established by
other means.
Human placental lactogen (HPL) is a protein produced by the
syncytiotrophoblast, and levels in the mother correlate, although
poorly, with placental and fetal weights (Hull and Chard, 1976). Like
oestriol assay, HPL estimation has been recommended as a screening test
to predict fetal distress (Letchworth and Chard, 1972; England et al.,
1974; Spellacy et al., 1975). It has also been advocated as a means
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of detecting the small-for-dates fetus, by Spellacy et al. (1976) who,
however, reported a detection rate of only 19% by HPL values less than
the generally accepted lower limit of normal (4 mg/ml) after J6 weeks.
Josimovich et al. (1970) and Zlatnik et al. (1979) found, respectively,
only 5 of 15 and 3 of 18 small-for-dates babies to be associated with
low HPL values. The more recently discovered placental proteins
(Schwangerschafts protein 1 and pregnancy associated plasma proteins A
and B) have, likewise, proved disappointing as indices of retarded
fetal growth (Trudinger et al.,1979» Hughes et al., 1980; Bischof and
Klopper, 1983).
Dunlop et al. (1978) reported increased haematocrit, and increased
haemoglobin and uric acid concentrations in a small series of small-
for-dates pregnancies. Increased haemoglobin concentration was con¬
firmed by Roller et al. (1979)» this finding presumably reflecting the
decreased plasma volume found in such pregnancies (Gibson, 1973) with
resulting haemoconcentration. There is insufficient evidence to
indicate that such tests would be suitable as screening procedures to
detect small-for-dates fetuses.
Whigham et al. (1980) compared plasma uric acid estimation with
total plasma oestriol, HPL, urine oestrogen/creatinine ratio and
Factor VIII related antigen coagulant activity ratio in detecting the
small-for-dates fetus. HPL assay proved better than the other hormonal
methods assessed, and uric acid concentration was confirmed to be
elevated in the small-for-dates group. However, the Factor VIII ratio,
an index of endothelial stress (Whigham et al., 1979)# proved most
useful by predicting 17 of the 21 babies that were small-for-dates at
birth.
There is a higher incidence of both pre-term and small-for-dates
infants born to mothers with elevated serum alpha-fetoprotein levels
during the second trimester, but this test does not provide sensitive
prediction of small-for-dates infants (Brock et al., 1980).
The presence or absence of phosphatidylglycerol (PG) in amniotic
fluid has been shown to be a very sensitive predictor of the risk of
respiratory distress syndrome in the newborn (Whittle et al., 1982).
Gross and colleagues (1980) have recommended amniocentesis to measure
PG concentration as a means of predicting small-for-dates infants.
Their paper is unconvincing. Having excluded normal birthweight babies
to study only those of low birthweight, they found that a concentration
of PG of more than 7% would differentiate small-for-dates fetuses from
normally grown pre-term babies with a sensitivity of 64% and a
specificity of 74%. This probably merely reflects differing mean
gestational age between these two groups which was unspecified. The
widely held belief that growth retardation accelerates fetal lung
maturation (Gluck and Kulovich, 1973) lacks confirmatory scientific
evidence (Gunston and Davey, 1978).
MISCELLANEOUS ASSESSMENT
Verma. et al. (1980) have proposed the hypothesis that fetal growth
retardation and pre-eclampsia result from a spectrum of maternal
vascular disorders which, if localised to the uterine vasculature
manifest as growth retardation, and, if generalised, manifest as pre¬
eclampsia (with or without growth retardation). The so-called "roll
over test" has been advocated as a means of predicting the development
of pre-eclampsia (Gant et al., 1974) and has been studied as a possible
means of predicting the delivery of a small-for-dates infant (Verma et
al., 1980). These latter authors found that 8 of 9 small-for-dates
babies were predicted by a positive roll-over test (in 4 of these
pregnancies there was associated pre-eclampsia); of the remaining 29
patients with positive tests, 16 developed pre-eclampsia without fetal
growth retardation and 13 were normal. This requires further study.
Russell and Lewis (1981) have recommended subjective assessment of
fetal fat thickness on X-ray films as a means of detecting the small-
for-dates fetus. Their assessments at less than 36 weeks, when
diagnostic information is of greater value, were less accurate than
those performed later in pregnancy. At this point it is relevant to
discuss radiological assessment of "maturity" in small-for-dates
fetuses. It is now standard teaching that the lower femoral epiphyses
appear on X-rays at around 36 weeks and the upper tibial epiphyses at
around 38 weeks (Hartley, 1957). There may, however, be a striking
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delay in epiphyseal appearance in small-for-dates fetuses. Thus, Scott
and Usher (1964) found that 37% of small-for-dates babies after 36
weeks had no radiologically detectable lower femoral epiphyses;
Robinson et al. (1979) found a bone age discrepancy of 3 to 4 weeks in
almost half the small-for-dates fetuses in their series.
In a small study of high risk patients MacDonald (1972) demonstrated
a higher incidence of small-for-dates babies (15%) born to mothers whose
cervical mucus displayed ferning after 16 weeks of pregnancy. This has
not, to the author's knowledge, been investigated further.
OBSTETRIC MANAGEMENT OF THE SMALL-FOR-DATES FETUS
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As discussed earlier in the chapter, some of the hazards of fetal
growth retardation may be a,voided by antenatal detection of the small-
for-dates fetus, with subsequent planned delivery by induction of labour
or elective Caesarean section at the optimal time. Among' factors which
influence such timing are the presence of other pregnancy complications
such as pre-eclampsia, previous obstetric history, the severity of growth
retardation as evaluated clinically or by ultrasound, assessment of
amniotic fluid volume, and the ripeness of the cervix (Calder, 1979).
Amniocentesis to assess fetal lung maturation is frequently of crucial
importance in deciding when delivery should occur. Earlier delivery
poses a greater risk of respiratory distress syndrome, failed induction
of labour and prolonged separation of the baby from the mother; later
delivery poses a greater risk of intrauterine death, intrapartum asphyxia
and severe variable decelerations of the fetal heart rate during labour
due to umbilical cord compression resulting from increasing oligohydram¬
nios. Of great value in identifying the optimal timing of intervention
are the results of assessment of fetal wellbeing. Such assessments may
be biochemical, such as oestriol or HPL estimation, or biophysical, such
as antepartum cardiotocography or observation of fetal breathing move¬
ments, and are discussed below. Whether intervention should take the
form of induction of labour or of elective Caesarean section is based
on the above factors and, like timing, needs to be individualised.
Continuous fetal heart rate monitoring' during labour should be
implemented in all cases as recommended by Odendall (1976) who found an
increased incidence of early, late and variable decelerations among
small-for-dates fetuses. Early recourse to fetal scalp blood pH
estimation should be undertaken because of the increased risk of
metabolic acidosis associated with fetal heart rate decelerations
(Lin et al., 1980) and the threshold for Caesarean section should be
lowered. The small-for-dates fetus appears to tolerate vaginal breech
delivery poorly (Hutchins, 1980). A paediatrician should be present at
delivery and the baby should be closely monitored after birth; early
feeding should be instituted to avoid hypoglycaemia.
The final part of this chapter will consider those techniques of
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assessment of fetal wellbeing which may allow the management of the
small-for-dates fetus and the planning of the timing and mode of
delivery to be performed in a rational and individualised fashion.
As has been discussed, biochemical assessments have proved to be
inaccurate means of detecting the small-for-dates fetus. Such tech¬
niques may, however, be of value after the fetus has been diagnosed
as small-for-dates by other means, by helping to differentiate between
those fetuses that are at particularly high risk of perinatal death
and damage, and those that are not. Few published reports consider
specifically small-for-dates pregnancies but Wilde and Oakey (1975)»
in a review of seven reports of oestrogen excretion in such pregnancies,
quote the combined perinatal mortality rate in the low oestrogen group
to be 37% compared with 27% in the normal oestrogen group; these very
high rates reflect, in part, the fact that most of the studies were
published during the 1960's. In a recent study (McFadyen et al., 1980)
urinary oestrogen excretion was low in all seven cases of intrauterine
death when assay was performed within one week of fetal demise; some
of the fetuses were small-for-dates. Assay of HPL, however, was not
found to effectively predict outcome of small-for-dates fetuses by
Josimovich et al. (1970) and Zlatnik et al. (1979).
Detection, by amniocentesis or amnioscopy, of meconium staining of
the amniotic fluid is of questionable value in predicting fetal out¬
come (Miller, 1979) and this technique has been generally superceded
by alternative means of antepartum assessment.
In conditions of chronic fetal hypoxia, such as may be found in
intrauterine growth retardation, fetal movement may decrease and then
cease some 24 to 48 hours before intrauterine death (Sadovsky et al.,
1974). Normal fetal movement, as monitored by "kick counts", is
generally associated with good outcome (Pearson and Weaver, 1976) and
this also applies to small-for-dates fetuses (Jarvis and MacDonald,
1979). Whilst kick counts are of undoubted value, more sophisticated
evaluation is usually necessary when the fetus is small-for-dates and
especially when fetal movement decreases.
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Boddy and Dawes (1975) described an absence of normal fetal breath¬
ing movements with the appearance of "gasping" some 24 to 72 hours
before the intrauterine death of 10 fetuses, "some of which" were
small-for-dates. The continued presence of normal fetal breathing
movements, in contrast, indicated good prognosis. Other workers have
also studied ultrasound assessment of fetal breathing movements as an
index of fetal wellbeing and some have found it useful (e.g. Trudinger
et al., 1979) whilst others have found prolonged fetal apnoea to be
not uncommon in association with good outcome (Fox and Hohler, 1977)•
A practical difficulty found with this technique is the large number
of extraneous factors which may influence fetal breathing, including
abdominal palpation and maternal smoking, eating and drug administra¬
tion. Other aspects of dynamic fetal function have also been studied.
It is possible, for example, to calculate the rate of fetal urine
production by repeated ultrasound measurement of fetal bladder volume
(Campbell et al., 1973). The rate of urine production may be greatly
decreased in small-for-dates fetuses, thus accounting for the fre¬
quently associated oligohydramnios, but this does not predict the
development of asphyxia during labour (Wladimiroff and Campbell, 1974).
The oxytocin challenge test (OCT), which involves antepartum contin¬
uous fetal heart rate recording while uterine contractions are
(usually) induced by oxytocin infusion, has been shown to be a useful
test of fetal wellbeing - a negative test (i.e. absence of repetitive
late decelerations) being a reliable indication of fetal health
(Freeman, 1975). This technique has been evaluated by Cetrulo and
Freeman (1977) in the management of 99 babies confirmed to be small-
for-dates at birth. The perinatal mortality rate was 18% in the 27
pregnancies with a positive OCT, and 1% in the remaining cases in which
the test was negative. Seven of the 11 perinatal deaths occurred ante¬
partum and three of these were predicted by a positive OCT. Because of
technical problems in some of the tests, however, the authors judged
that there was only a single genuine false-negative test. Schulman et
al. (1977) found in a study of OCT in high risk pregnancies that 33% of
fetuses with positive tests were small-for-dates at birth. Although the
OCT is useful in evaluating fetal condition and utero-placental reserve,
it is time-consuming, possibly occasionally dangerous and not easily
repeatable and, in consequence, non-stress antepartum cardiotocography
has been increatingly employed in the assessment of high risk preg¬
nancies (Flynn and Kelly, 1977). This was evaluated by Flynn et al.
(1979) in 57 pregnancies which terminated in the delivery of a small-
for-dates infant (birthweight less than the 10th percentile).
Surprisingly only four of these fetuses had normal reactive traces but
this indicated a good prognosis; of 16 fetuses showing ominous traces
with repetitive late decelerations, six died before labour and five of
the remaining 11 had low Apgar scores. The consensus of opinion is
that normal antepartum cardiotocography indicates good prognosis and
can allow conservative management until a suitable time for delivery.
Abnormal traces indicate poorer prognosis depending on the severity of
the abnormality, but the finding of an abnormal trace does not
necessarily predict poor fetal outcome (McCune et al., 1983). It is
the opinion of the author that antepartum non-stress cardiotocography
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HISTORY
The history of the development of ultrasound as a diagnostic tool
has been charted by Kratochwil (1978). As a direct result of the
sinking of the transatlantic passenger liner, Titanic, the first
practical application of ultrasound was to determine the position of
icebergs; further advances in the application of ultrasound to marine
technology occurred during the First World War with the need to detect
German submarines blockading the United Kingdom. Following that war,
the technique was used in industry to detect flaws in metal structure.
The first exercise to use ultrasound as a diagnostic technique in
medicine was by the Austrian neurologist Dussik in 1938. His attempts
to outline the adult brain and its ventricles failed because of the
high acoustic impedance of skull bone. Further refinements were made
in ultrasound instrumentation during the Second World War for military
purposes and, using war-surplus equipment, Howry in 1947 in Denver
started to investigate the potential of ultrasound in medical diagnosis.
Later, with Holmes, he produced high quality images of upper abdominal
organs but his system had the important disadvantage that it necessitated
the immersion of the patient in a bath of water. In 1954• Professor Ian
Donald in Glasgow started his research from which ultrasound was to
emerge as a practical and useful diagnostic technique. Donald has
recently recounted the, often amusing, story of the first steps in this
process (Donald, 1980). Together with an engineer T.G. Brown, he con¬
structed the first contact ultrasound scanner which, because the ultra¬
sound transducer was brought into direct contact with the patient's
skin, made diagnostic ultrasound a practical proposition. In a series
37.
of publications Donald and colleagu.es described the usefulness of
ultrasound in the differential diagnosis of abdominal masses (Donald
et al., 1958; Donald, 19^3)9 the diagnosis of hydatidiform mole
(Donald and Brown, 1961) and the detection of blighted ova, twin
pregnancies and placenta praevia (Donald and Abdulla, 1967). From
these beginnings diagnostic ultrasound became established in obstetric
practice, and most sophisticated maternity units throughout the world
now possess ultrasound equipment. Of the many uses to which ultrasound
has now been applied in obstetrics those of relevance to this thesis,
namely assessment of gestational age and of fetal growth and size, will
be discussed in detail later in this chapter.
PHYSICAL AND TECHNICAL ASPECTS OF ULTRASOUND
Ultrasound may be defined as mechanical vibration occurring at
frequencies above the range of human audibility, i.e. above about 16 kHz.
In diagnostic work frequencies of several million cycles per second are
used (MHz). Within this range, ultrasound exhibits certain special
properties; of diagnostic importance is the possibility of producing
focussed or highly directional beams. The original static ultrasound
scanners utilised a single disc-sha.ped slice of piezo-electric ceramic
to convert electrical energy to ultrasound energy and vice versa. The
piezo-electric effect had been discovered by the Curie brothers during
the nineteenth century but their findings were ignored for decades
(Kratochwil, 1978). The two flat surfaces of the piezo-electric crystal
disc are coated in metal to form conducting electrodes. When a voltage
is applied across the elctrodes in one direction, the disc becomes
thicker with a smaller radius; a voltage applied in the opposite
direction causes the disc to become thinner with a greater radius.
Application of an alternating voltage thus results in a forwards and
backwards movement of the transducer face to propogate waves of sonic
energy. Each time the face moves forward a new crest is formed; the
distance that separates the crests is the wavelength.
The physical aspects of diagnostic ultrasound have been compre¬
hensively reviewed by Talbert and Campbell (1972). Different tissues
provide different degrees of impedance to the passage of ultrasound and
this enables reflection to occur at tissue interfaces. The process of
reflection is crucial in providing diagnostic information with ultra¬
sound, and the reception and processing of reflected echoes will be
discussed shortly. The ideal ultrasound beam would be needle thin to
give the finest detail, but this is not possible because ultrasound
shares with other forms of wave energy the property of diffraction.
Higher frequencies produce more precise beam formation, and focussing
is an alternative means of overcoming the effects of diffraction, at
least around the focal point of the bean. Refraction, another property
of wave motion, is of minimal importance in obstetric ultrasound where
thick bone layers do not lie in the beam path.
Essentially, ultrasound systems are used to determine the position
of a structure. A short burst of ultrasound, lasting1 a few cycles, is
repetitively transmitted into the tissue to be investigated (pulsed
ultrasound). After each pulse the electronic circuitry supplying the
transducer is effectively disconnected and the receptor electronics
activated. When an interface of tissues of different acoustic impedance
is situated in the path of the beam, some of the ultrasound is reflected.
The piezo-electric crystal of the transducer has the additional and
converse property of generating a voltage across the terminals when it
is mechanically stimulated by reflected ultrasound energy# This is
detected by the receptor electronic system. Combining the information
received - that an echo occurred, that the transducer was positioned at
a certain angle, and that the echo was received a certain measured time
after transmission - the ultrasound system can determine the position
of a structure. By transmitting the ultrasound beam into a complex
biological medium, such as the uterus and fetus, a series of echoes are
reflected from the different tissue interfaces. This information may be
displayed in different ways. The simplest display is the A-mode, so-
called from its use in radar (Talbert and Campbell, 1972). The A-mode
provides a simple linear display, with received echoes appearing as
peaks, and it was formerly used almost universally as the optimal means
of fetal measurement. Artificial echoes ("electronic calipers") were
employed in most systems to be superimposed on the A-mode display to
calculate distance, based on the time delay between reception of echoes
and the assumed sound velocity in the tissue investigated. Information
may also be displayed in the time-position (TP) mode which is a graphical
display depicting, in effect, the A-mode display over a period of time.
This is convenient for demonstrating rapid tissue movement and has been
widely used in echocardiography but has little practical application in
obstetric work. The B-mode display builds up a two-dimensional image of
the tissues underlying the sweep of the transducer, as moved by the
operator. This necessitates the equipment "knowing" where the transducer
is positioned and at what angle it is directed at all times. This can
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provide a high quality image as long as significant tissue movement
does not occur while the display is being constructed.
The above remarks relate mainly to the single transducer static B
scanners which were, for several years, the only commercially available
diagnostic ultrasound systems. More recently alternative forms of
ultrasound equipment have become available (Hall, 1980). The most
successful have been the real-time linear-array scanners (Campbell and
Little, 1978). These equipments produce a two dimensional "moving"
image from a long hand-held transducer. The linear-array transducer is
comprised of many elements, different groups of which are energised in
sequence. Compared with the static B scanner, real-time scanners are
less expensive, simpler to operate and are particularly useful for study
of what is often a continuously moving structure, namely the fetus. In
most aspects of obstetric ultrasound the real-time scanner is at least
as useful as the static B scanner; in the opinion of the author,
exceptions are precise fetal measurement and possibly placentography.
Alternative types of ultrasound equipment include mechanical real-time
scanners (which have a small scanning head with internal rotating
transducers designed to provide a sector scan), phased-array scanners
(which also provide a sector scan but by using variable electronic
delays rather than mechanical rotation), water bath scanners (more
sophisticated versions of the original Howry model which produce very
high quality images via an immersed transducer rather than of an
immersed patient) and Doppler scanners (which are suitable for the
study of flow dynamics in blood vessels).
The ultrasound equipment employed in the studies reported later in
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this thesis were of the linear-array real-time or static B scan types.
The former equipment (mainly Diagnostic Sonar Systems 85 and 185»
Livingstone, Scotland) were used for assessment of gestational age in
early pregnancy. The latter equipment (Diasonograph 4102, Nuclear
Enterprises/now Fischer Ultrasound, Edinburgh, Scotland) was used for
ultrasound measurement during the third trimester (Figure 2 - 1). In
addition to standard measuring facilities on the Diasonograph, an
electronic area and circumference measuring system (Figure 2-2) was
used for certain fetal measurements during third trimester ultrasound
study. This system was constructed by J.E.E. Fleming and A.J. Hall in
the obstetric ultrasound laboratory at the Queen Mother's Hospital,
Glasgow. Similar systems have become available commercially since
these studies were commenced. This system has been described in detail
elsewhere (Fleming et al, 1978) but will be described briefly here:
Modern diagnostic ultrasound equipment utilises analogue or
digital scan converters which provide grey-scaled images and
thus improved picture quality when contrasted to the old direct-
view storage tube displays (Hall, 1980). However, for technical
reasons, the television monitors which are necessary to display
the grey-scaled images introduce spatial distortions and
uncertain scale factors which mean that accurate measurements
cannot be obtained directly from these displays (Fleming et al.,
1978). The Fleming and Hall system uses the standard electronic
calipers of the Diasonograph to permit measurement at an earlier
stage in image processing. As far as the operator is concerned,
however, measurement appears to take place on the high quality
grey-scaled image; one caliper dot is positioned in the centre
of the image to be measured, the other is steered around the
periphery using the remote joystick (Figure 2-2). The radius
is measured at constant angular increments and area and circum¬
ference measurements thus automatically calculated. In a water
bath experiment to study accuracy of measurement, mean errors
of only 1.896 (circumference) and 2.5% (area) were obtained;
corresponding figures using a map measurer for circumference and
a planimeter for area were 5.5% and 5«5% respectively (Fleming
et al., 1978). The measuring system is not only more accurate
but it is easier and quicker to use than alternative techniques.
Diasonograph 4102, Nuclear Enterprises, Edinburgh.
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Figure 2 - P
The electronic area and perimeter measuring device.The joystick is on the right.
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SAFETY
Following the findings of Stewart and colleagues (1956; 1958) that
the incidence of childhood malignancy is increased after prenatal
exposure to X-rays, much attention has been paid to the subject of
whether ultrasound examinations may be harmful to the developing fetus.
This has been comprehensively reviewed by Hill (1968), Taylor and
Dyson (1972), Donald (1976), Febrikant (1977), Abdulla (1978) and
Baker and Dalrymple (1978).
Ultrasound may have the following three effects in biological tissue :
cavitation, thermal effects, and "direct" effects as proposed by Hill
(1978). Cavitation is more likely to occur with constant insonation, and
it is probably completely absent when ultrasound is transmitted in pulses
as in diagnostic work (Hill, 1968; Donald, 1976). Thermal effects are
also insignificant since a rise in temperature can be induced only by
energy levels far in excess of those used diagnostically. The "direct"
effects represent as yet uncertain mechanisms of action on tissue and
if harm does result from insonation it is probably by these mechanisms.
Many in vitro experiments have been performed to assess the safety of
ultrasound (see Abdulla, 1978). The only report to describe evidence
of damage was that of Macintosh and Davey (1970) which appeared to
demonstrate ultrasound - induced chromosomal damage. After much con¬
troversy the principal author was unable to replicate these findings and
attributed his original results to experimental artifact (Macintosh et
al., 1975). Animal studies have failed to indicate any harmful effect
at energy levels used for diagnostic work. A study of fetal outcome
after ultrasound examination, carried out in New York, Glasgow and Lund,
showed no adverse features in the insonated group (Hellman et al., 1970).
Deafness is not more common after in utero exposure to ultrasound
(Donald, 1976).
The consensus of opinion is that diagnostic ultrasound has a wide
margin of safety and there has been no evidence of harm demonstrated
after exposure to ultrasound at diagnostic energy levels.
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ULTRASOUND ASSESSMENT OF GESTATIONAL AGE
Accurate knowledge of gestational age is important in modern
obstetric practice to allow detection of the small-for-dates fetus by
clinical or other means and to indicate the optimal timing of induction
of labour or elective Caesarean section, when indicated. In addition,
the normal values of some tests of fetal wellbeing and of others used
to help detection of fetal anomalies (e.g. maternal serum alpha-feto-
protein) change as pregnancy advances; a knowledge of gestational age
is necessary for proper interpretation. Usually gestational age is
calculated from the date of the start of the woman's last menstrual
period. However, this calculation was found to be unreliable, for a
variety of reasons, in 40% of patients attending the Queen Mother's
Hospital (Robinson, 1978). Ultrasound measurement of the fetus in early
pregnancy has been shown to be more accurate in the estimation of
gestational age than alternative means of assessment including clinical
examination (even in the first trimester) (Beazley and Underhill, 1970),
the date of quickening (Grennert et al., 1978) or radiological evalua¬
tion in late pregnancy (Robinson et al., 1979).
In early pregnancy fetal growth is rapid, there is little biological
variation in fetal size, and pathological growth retardation is uncommon.
For these reasons measurement of fetal size by ultrasound provides
accurate estimation of gestational age. During the first trimester fetal
crown-rump length is measured using the technique of Robinson (1973);
this is accurate to within ± 5 days in 95% of cases (Robinson and
Fleming, 1975) and has proved more accurate than gestation sac volume
measurements (Robinson, 1975). The original work on crown-rump length
measurement was performed using static B scanners, but Adam et al. (1979)
have shown that accurate measurements may be obtained using real-time
systems.
The standard ultrasound method of assessing gestational age during
the second trimester is by measurement of the fetal biparietal diameter
(BPD). Most of the important original work on this was performed by
Campbell, initially in Glasgow and subsequently in London. Using his
combined A and B mode technique (Campbell, 1968) on static B scanners,
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BPD measurements are highly accurate, (Campbell, 1970) and reproducible
(Campbell, 1973)* More recent reports have also shown BPD measurements
using real-time scanners to be accurate (Docker and Settatree, 1977?
Adam et al., 1978; Osinusi et al., 1980). BPD growth averages 2.8 mm
per week between 20 and 30 weeks, and 1.5 mm per week after 30 weeks
(Campbell, 19^9)- This together with the progressively greater biological
scatter of BPD values as pregnancy advances, reinforces the point that
ultrasound measurement to assess gestational age is maximally accurate
when performed as early as possible in pregnancy. BPD measurement
before 30 weeks will predict the date of delivery to within _ 2 weeks
in 80% of patients with "unknown dates" (Underhill et al., 1971)•
Recently ultrasound measurement of femoral length during the second
trimester has been proposed as an alternative or additional means of
assessing gestational age (O'Brien et al., 1981).
ULTRASOUND ASSESSMENT OF FETAL GROWTH
The BPD may also be measured serially during the third trimester to
assess fetal growth. Using only a simple A-mode system, Willocks and
colleagues showed that serial biparietal cephalometry could identify
the small-for-dates fetus (Willocks et al., 1965? 1967? Willocks,
1971). Subsequently Campbell, using his combined A and B mode technique,
constructed BPD charts based on the measurement of normal fetuses from
13 weeks of pregnancy (Campbell and Newman, 1971) and showed that up to
73% of small-for-dates fetuses could be detected antenatally by serial
measurement of the BPD (Campbell and Dewhurst, 1971). Different patterns
of abnormal BPD growth may be delineated, including 'late flattening'
(abrupt cessation of growth, usually in late pregnancy), 'low growth
profile' (subnormal growth rate from early pregnancy - the pattern seen
in growth retardation associated with fetal anomaly; Campbell, 1974b)
and 'catch-up-growth' (transient cessation of growth with subsequent
acceleration; Bamford et al., 1977). Serial biparietal cephalometry
has been compared with urinary oestrogen assay (Campbell and Kurjak,
1972; Robinson et al., 1973) and found to be superior in the detection
of small-for-dates fetuses although a combination of both techniques
proved more efficacious than either alone.
Several problems are, however, encountered in the use of serial
biparietal cephalometry. For accurate measurement of the BPD, the
correct angulation of the ultrasound transducer is crucially important
(Watmough et al», 1974; Blackwell, 1978). This is often difficult and
may be impossible when the fetal head is in a direct occipito-anterior
or occipito-posterior position or when it is low in the maternal pelvis
the accuracy of BPD measurement is highly dependant on the skill and
experience of the operator (Davison et al., 1973a; 1973b; Campbell,
1973). Further, to be of value BPD measurement must be performed on
repeated occasions thus delaying the diagnosis that the fetus appears
growth retarded and, for logistic reasons, restricting the number of
patients in whom this procedure may be performed. Robinson
(personal communication) analysed retrospectively the results of serial
biparietal cephalometry, performed on 331 high risk patients at the
Queen Mother's Hospital, to evaluate this technique in actual practice.
He found that no less than 93 of the BPD curves (28%) were difficult or
impossible to interpret for a variety of reasons; only 25 of the 39
babies which were small-for-dates at birth (64%) had had demonstrably
abnormal BPD growth curves; and of the 71 fetuses with abnormal BPD
curves only 25 (35%) were small-for-dates at birth. Thus, in ordinary
practice in a reputable obstetric ultrasound unit, serial biparietal
cephalometry is associated with high false-negative (36%) and false-
positive (23%) rates. One of the reasons for the high false-negative
rate (failure to detect the small-for-dates fetus) is the so-called
'brain sparing' effect (see below).
If organ weights of small-for-dates infants are compared with those
of normally grown controls of similar gestational age or of similar
birthweight (i.e. pre-term infants), marked differences are seen
(Gruenwald, 1974). Those organs most reduced in size by intrauterine
growth retardation are the spleen, liver and thymus; the brain, in
contrast, is preferentially protected from the effects of growth
retardation. Thus in Gruenwald's comparison of the organ weights of
small-for-dates and pre-term infants, the mean liver weight of the
small-for-dates group was less than that of the controls while brain
weight was 40% greater. Similar findings can be demonstrated by animal
experiments in which fetal growth retardation is induced by ligation of
vessels supplying the placental bed (Winick, 1971), and among infants
dying of alimentary malnutrition during the first months of life (Naeye,
1965c). It should be stressed that this phenomenon of brain sparing
refers to the physical size of the organ and implies little about the
possible effects of intrauterine growth retardation on the functional
capacity of the developing brain (Hull et al., 1978). Also worthy of
note is the fact that, despite the brain sparing effect, the brains of
small-for-dates infants are of less mean weight than those of normally
grown babies of similar gestational age (Gruenwald, 1974); the effect
is relative. Nonetheless, these findings are of importance to the
detection of the small-for-dates fetus by ultrasound measurement.
Serial biparietal cephalometry involves measurement of an index of the
size of the fetal organ (the brain) that is least affected by growth
retardation. This is illogical and accounts in part for the false-
negative rates obtained with serial biparietal cephalometry.
Recently, therefore, ultrasound measurement of alternative fetal
parameters has been investigated; this work has been reviewed by Deter
et al. (1981; 1982). As early as 1965* measurement of the fetal thorax
was described as a means of assessing fetal size (Thompson et al, 1965)»
although more recently attention has focused on measurements of the fetal
abdomen (or trunk) at the level of the fetal liver because of the par¬
ticular impact of intrauterine growth retardation on this organ. The
umbilical vein has generally been taken as the marker for identification
of the standard transverse fetal section (Campbell and Wilkin, 1975;
Hansmann, 1977) and this practice has been followed in the studies on
which this thesis is based. It has been suggested that, because the
confluence of the umbilical vein with the portal sinus lies in the true
transverse axis of the fetus, this should be used as the best landmark
(Morin and Winsberg, 1978).
Garrett and Robinson (1971) described serial measurement of the fetal
trunk (in a section between the heart and kidney) as an adjunct to
measurement of the fetal head in attempting to detect the small-for-dates
fetus; they did not report whether improved detection was obtained with
trunk or with head measurements. Campbell and Wilkin (1975) described
measurement of trunk circumference as a means of predicting birthweight.
Using a computerised extrapolation of available data they came to the
conclusion that the optimal gestational age at which to screen for the
small-for-dates by a single trunk circumference measurement would be 32
weeks, when it was predicted that there would be a false-negative rate
of 13% and a false-positive rate of "\%. This exercise, however, seemed
to be based on the assumption that small-for-dates and other fetuses
remain in the same percentile size band throughout pregnancy; that this
does not always happen can be demonstrated by serial biparietal
cephalometry. Subsequent work by King's College Hospital team have
shown quite different results on prospective study (Little and Campbell,
1982). Many other workers have reported a prediction of birthweight by
various ultrasound measurements performed shortly before delivery
(Thompson and Makowski, 1970; Ianniruberto and Gibbons, 1971;
Higginbottom et al., 1975; Kurjak and Breyer, 1976; Lunt and Chard,
1976; Picker and Saunders, 1976; Campogrande et al., 1977; Warsof et
al., 1977; Kearney et al., 1978; McCallum and Brinkley, 1979; Poll
and Kasby, 1979; Sampson et al., 1982). These studies are not directly
relevant to this thesis and will not be discussed except to conclude
that, generally, trunk measurements have been found to be better pre¬
dictors of birthweight than have head measurements although some studies
have found a combination of both to be best (Lunt and Chard, 1976;
Sampson et al., 1982). Two studies have indicated that fetal length
should also be measured (Picker and Saunders, 1976; McCallum and
Brinkley, 1979).
In an attempt to distinguish between different types of growth retar¬
dation (rather than to detect the small-for-dates fetus) Campbell and
Thorns (1977) reported on calculation of the ratio of head circumference
to trunk circumference. As discussed earlier, the small-for-dates group
is heterogeneous, the type and severity of risks faced by individual
small-for-dates fetuses varying greatly. Identification of the particular
type of growth retardation in an individual case may be of prognostic
value and useful in clinical management. In growth retardation resulting
from utero-placental insufficiency the neonotes characteristically have
a wasted malnourished appearance with heads large in comparison to
trunks (asymmetrical growth retardation). Typically these fetuses have
late flattening BPD growth curves (Garrett and Robinson, 1971; Campbell,
1974b) and a high incidence of perinatal asphyxia and neonatal hypo-
glycaemia (Campbell, 1974b) as one would expect as a consequence of
utero-placental insufficiency. The other group of small-for-dates
babies do not appear wasted at birth and are symmetrically growth
retarded with overall small dimensions. Characteristically, their
serial BPD curves show a low growth profile pattern (Campbell, 1974b).
In contrast to the late flattening group, Campbell attributes the small
size of these infants to low growth potential despite an intrauterine
environment satisfactory to maintain normal growth. Thus, fetuses which
are abnormal (especially chromosomally abnormal) or have suffered a
major insult during the critical period of organogenesis (e.g. by rubella
infection) or are small because of their genetic endowment, would be
expected to fall into this group. (Campbell, 1974b) found that, if
abnormal fetuses were excluded from consideration, the low growth
profile group had a lower incidence of perinatal problems than the late
flattening group although he did not quantify the relative risks in
each group.
In a further attempt to distinguish between these two groups of small-
for-dates fetuses, Campbell and Thorns (1977) used the ratio of head to
trunk circumferences. The ratio was determined in 31 small-for-dates
fetuses within one week of delivery; 22 (71%) had ratios above the 95th
percentile (asymmetrical growth retardation) and the rest had normal
values (symmetrical growth retardation). While there was a higher
incidence of intrapartum fetal distress and of operative delivery in the
asymmetrical group, the perinatal mortality and incidence of low Apgar
Scores were similar and high in both groups. Two babies had congenital
defects (cystic fibrosis and rubella embryopathy) and both were
symmetrically growth retarded.
Studies of postnatal growth in sma11-for-dates infants are of relevance
to attempts to correlate abnormal intrauterine growth patterns with their
pathogenesis. Fancourt et al. (1976) showed that those small-for-dates
babies that had been shown to manifest slow BPD growth before 34 weeks of
pregnancy had, as a group, smaller head circumferences, heights and
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weights at between 28 and 34 months of age than did the small-for-dates
groups which either did not demonstrate slowing of BPD growth until
after 34 weeks or did not show abnormal BPD growth. Davies et al.(l979)
in a different study classified their small-for-dates infants into
asymmetrically and symmetrically growth retarded groups according to
the Ponderal Index (Miller and Hassanein, 1971). They found that, with
the exception of weight gain in the symmetrical group during the first
month, weight gain and length and head circumference growth was con¬
sistently greater during the first three months of life in both small-
for-dates groups compared with infants of normal birthweight. Since
both asymmetric and symmetric groups demonstrated catch-up growth
following delivery it would appear that environmental growth restraint
was operating in both groups. It may well be that, on the question of
asymmetry and symmetry, the time of the impact of the growth retarding
factor is of greater importance than the actual nature of the insult.
Further study of this matter is clearly required, but in the light of
available knowledge all small-for-dates fetuses should be regarded as
high risk and managed accordingly.
Whilst Campbell and Thorns (1977) used head-trunk ratios to investigate
the type of growth retardation, other workers have used similar measure¬
ments to detect the small-for-dates fetus. Overall, there have been few
published reports on the use of trunk measurements to detect the small-
for-dates fetus and these will be discussed in some detail.
Wladimiroff and colleagues (1978) studied the ultrasound measurement
of 303 normal and 84 small-for-dates fetuses (defined as having a birth-
weight less than the 10th percentile). The BPD was measured and head
area calculated by squaring the BPD value (at best an approximation of
head area); chest area was measured, using a planimeter, immediately
below fetal cardiac pulsation on a transverse section that included part
of the fetal liver (Wladimiroff et al., 1977). Judging from the data in
their 1978 paper most of the measurements in the small-for-dates fetuses
were carried out after 36 weeks. Of the 84 small-for-dates fetuses 36
(42%) had. small BPD measurements and 63 (75%) had small chest area
measurements, indicating better detection by the latter parameter;
false-positive results were not reported. A minority of small-for-dates
fetuses (36%) had abnormal head-chest area ratios.
Varma and colleagues (1979) carried out various measurements on 186
high risk fetuses at both 33 weeks and within 10 days of delivery; 35
of these were small-for-dates at birth (birthweight less than 10th
percentile). Rates for the detection of small-for-dates fetuses at 33
weeks were 57% (head area), 71% (thoracic area), 80% (trunk area -
measured at umbilical vein), and 83% (head-trunk area ratio) with false-
positive rates ranging from 8 to 11%. Corresponding figures for measure¬
ments performed within 10 days of delivery were 74% (head area), 83%
(thoracic area), 83% (trunk area) and 86% (head-trunk area ratio) with
similar false-positive rates. The results found with head-trunk area
ratios in this study are substantially different from those obtained by
head-chest area ratios by Wladimiroff et al. (1978).
Crane and Kopta (1979) reported 100% detection of small-for-dates
fetuses by head-trunk circumference ratios, with a nil false-positive
rate. Their study included only 47 pregnancies, in all of which there
was pre-existing evidence of fetal growth retardation; only 10 babies
were small-for-dates at birth but the criteria used to define small-for-
dates were not specified.
Another reported study is that of Kurjak et al. (1980). The nature
of their selection of the 260 small-for-dates fetuses studied is puzzling
as they were apparently selected as the only small-for-dates infants born
from 40,000 pregnancies screened by ultrasound in Zagreb over a five year
period. Small-for-dates was defined as birthweight less than the 10th
percentile and much larger numbers would therefore be anticipated.
Measurements performed included a single BPD measurement, serial
biparietal cephalometry, trunk circumference (TC) and head-trunk circum¬
ference ratio (HTCR). Not all of these measurements were performed in
all cases; thus, 188 patients underwent serial cephalometry and only
62 TC measurements were made. The gestational age when these measure¬
ments were performed was not specified. Detection rates of small-for-
dates fetuses were reported as follows: 49% (single BPD), 52% (serial
cephalometry), 84% (TC) and 80% (HTCR): false-positive rates were not
mentioned.
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At the Queen Mother's Hospital, Wittmann et al. (1979) investigated
the measurement of nine different fetal parameters as possible screening
techniques for the small-for-dates fetus using a single ultrasound
examination. To assess the best method and timing of measurement, ultra¬
sound examination was performed on 255 women at approximately 32, 34 and
36 weeks. Definition of small-for-dates was birthweight less than the
10th percentile according to the chart of Lubchenco et al. (1963)» which
approximately corresponds to the local Glasgow 5"th percentile, and 16
infants were classified as small-for-dates at birth. Detection rates of
these small-for-dates fetuses were : 44% (BPD), 71% (trunk area - TA)
and 40% (crown-rump length -CRL). Similar results were obtained with
the other single measurements (occipitofrontal diameter, head area,
head circumference, transverse trunk diameter, antero-posterior trunk
diameter and trunk circumference). Combination of measurements proved
more effective, the best combination being the product of crown-rump
length and trunk area (CRL X TA) which had an overall false-negative
rate of 33% and a false-positive rate of 6%. However, after 235 days
(33 weeks 4 days) the results were excellent, only two of 17 measure¬
ments from small-for-dates fetuses being above the demarcation line
giving a false-negative rate of only 12%. Of the different head to
trunk ratios assessed, the ratio of the areas proved most effective
although it detected only 50% of the small-for-dates fetuses; there
was an even distribution of false-negative results throughout the study
period.
Duff and Evans (1981) also studied single ultrasound examinations
during the third trimester. BPD, TA and TO (the latter parameters
measured at the level of the umbilical vein) were measured at around
34 weeks in 140 patients, 16 of whom produced small-for-dates infants
(birthweight less than the 10th percentile). Using the product of BPD
and TC (or TA), 75% (or 69%) of small-for-dates fetuses were detected
with a false-positive rate of 16%.
Eik-Nes et al. (1983) studied the timing of single ultrasound measure¬
ment to detect the small-for-dates fetus. 606 unselected patients were
studied; all had undergone BPD measurement to assess gestational age at
17 weeks. At approximately 33 and 38 weeks further ultrasound examina¬
tion was performed to measure the BPD and the 'trunk diameter' (the mean
of antero-posterior and transverse trunk diameters measured at the
umbilical vein). Small-for-dates was defined as birthweight 20% or more
below the mean (approximately the 6th percentile) and there were 26 such
small-for-dates babies at birth. Using a nomogram constructed from a
previous study (Eik-Nes et al., 1982) which was designed to predict
birthweight deviation from the mean, the following results were obtained
at 33 weeks the false-negative rate was 23% and the false-positive rate
22%; at 38 weeks the false-negative rate was 17% and the false-positive
rate 22%.
Another ultrasound technique which has been used to detect the small-
for-dates fetus, especially in the United States, is measurement of
total intrauterine volume (TIUV), introduced by Hobbins in Yale. The
rationale for this procedure is based on the fact that not only are
small-for-dates fetuses small in themselves, but the placenta also tends
to be small and the volume of amniotic fluid tends to be reduced thus
resulting in overall reduced intrauterine volume. TIUV is calculated
from three measured linear dimensions of the uterus. In the initial
study of 96 high risk patients, 25 produced small-for-dates infants
(birthweight less than the 10th percentile); 21 of these small-for-
dates fetuses (75%) had abnormal TIUV measurements (Gohari et al., 1977%
Surprisingly none of the normally grown babies had TIUV results below
the demarcation line (minus 1.5 standard deviations from the mean as
derived from measurement in normal pregnancies) but this may reflect
the small numbers involved. Levine et al. (1979) studied prospectively
9 small-for-dates fetuses (birthweight less than the 5th percentile) and
found abnormal TIUV measurements in all. cases. These authors did not,
apparently, study normal patients prospectively to evaluate the false-
positive rate. Middleton et al (1982) have been unable to replicate the
results of Gohari and colleagues and have found large inter-operator
variability in TIUV measurement (13%). Middleton's study was retro¬
spective and included 99 patients suspected of having a small-for-dates
fetus; 20 measurements were obtained from babies which were small-for-
dates at birth (birthweight less than 10th percentile). Analysis showed
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that only 9 of the TIUV measurements (45%) obtained from these small-for-
dates pregnancies had been abnormal. Whilst several of these measurements
were obtained during the second trimester, the distribution of false-
negative results appeared fairly even throughout the second half of
pregnancy.
In the opinion of the author measurement of TIUV replicates many of
the problems associated with abdominal palpation. Amniotic fluid may
or may not be reduced in volume in small-for-dates pregnancies, and in
cases of growth retardation associated with fetal anomaly there may exist
polyhydramnios. The ultimate object of interest is the fetus and ultra¬
sound measurement should be concentrated on it.
Prom review of all the above reports the following general points may
be made :
1. There is a shortage of good studies designed to investigate
the effectiveness of ultrasound-measured fetal parameters,
other than the BPD, in the detection of the small-for-dates
fetus.
2. Available information indicates that trunk measurements are
more effective than head measurements, as would be expected
from knowledge of the brain sparing effect.
3. Little is known about the value of serial measurement of
trunk dimensions.
4. There are enormously different reported results of the
percentage of small-for-dates fetuses with abnormal head-
trunk ratio measurements. At present it would seem that
these measurements are better employed to investigate the
type of growth retardation in an individual case than to
detect the small-for-dates fetus, although the significance
of symmetrical and asymmetrical growth retardation is still
far from clear.
5. Whether diagnostic ultrasound provides a practical and
effective means of screening for the small-for-dates fetus
by a single ultrasound examination during the third
trimester requires further study.
CHAPTER 3.
DEVELOPMENT OF A MEANS FOR SCREENING FOR




As discussed in Chapter 1, there are a variety of reasons why an
individual fetus may be small-for-dates at birth and the associated
risks will vary according to the aetiology. The small-for-dates group
as a whole, however, have a higher perinatal mortality rate than
babies of normal birthweight (Gruenwald, 1964; Lugo and Cassady, 1971;
Usher, 1971; Alberman, 1974; Naftolin and Usher, 1978; Mcllwaine, et
al., 1979a; Dobson, et al., 1981). While the majority of these deaths
are stillbirths (Mcllwaine, et al., 1979a), the neonatal mortality rate
is also increased (Lubchenco, et al., 1972). The additional hazard of
perinatal asphyxia (Low, et al., 1972; Perry, et al., 1976; Oh, 1977)
may, like intrauterine death, be avoidable by planned delivery at an
optimal time and under optimal circumstances. There therefore appears
a vital need for an effective method for screening for small-for-dates
fetuses early enough to permit intensive biochemical and biophysical
monitoring of the state of fetal wellbeing on which to base further
management, a policy which may be expected to result in improved peri¬
natal mortality and morbidity and long term outcome.
The simple clinical techniques of abdominal palpation (Campbell,
1974; Hall et al, 1980; Rosenberg, et al., 1982a) and tape measurement
of fundal height (Rosenberg, et al., 1982b) are not effective in
detecting the small-for-dates fetus. It has been suggested that the
clinical detection rate may be improved by instituting a special ante¬
natal clinic to deal specifically with the problem (Beard and Roberts,
1970) but for this to be successful, all appropriate high risk patients
must be selected for closer scrutiny. As discussed on page 25, there are
major limitations in the risk assessment approach to the antenatal
identification of the small-for-dates fetus, and this has been confirmed
by our own experience (Neilson, 1979)i A comprehensive list of at-risk
criteria (Table 3-1) were applied retrospectively to the first 500
patients to be delivered in the Queen Mother's Hospital in 1977. It
was found that 23% would have been included in the high-risk group and
that 58% of the small-for-dates babies were born to these mothers.
Exclusion of maternal age as a criterion reduced the high-risk group to
more manageable proportions (16%) but only 43% of small-for-dates
infants were then included.
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TABLE 3 - 1
CRITERIA EMPLOYED IN EVALUATION OF RISK ASSESSMENT TO PREDICT
SMALL-FOR-DATES INFANTS
1. EPIDEMIOLOGICAL FACTORS:







Moderate or severe pre-eclampsia
Antepartum haemorrhage










Ultrasound measurement of the fetus, which has been discussed in
detail in the preceding chapter, would appear the ideal screening tool.
The study described in this chapter aimed at the development of a means
for screening for the small-for-dates fetus by a two-stage ultra¬
sound examination schedule. The first-stage examination was an
accurate assessment of gestational age in early pregnancy, the second
an assessment of fetal size at between 34 and 36 weeks.
PATIENTS AND METHODS
The study group comprised 474 patients with singleton pregnancies.
Of these, 90 09%) had been referred for serial biparietal cephalometry
because of past or current pregnancy complications; the remainder were
low-risk volunteers from the antenatal clinic. At any single session
all patients attending the clinic whose pregnancy had advanced to
between 34 and 36 weeks were asked to participate in the study, and
less than 10% declined. All had undergone ultrasonic examination
before 28 weeks, at their first visit to the antenatal clinic (in
accordance with established hospital policy), when gestational age was
assessed by measurement of fetal crown-rump length up to 14 weeks
(Robinson, 1973), or the biparietal diameter, from 13 weeks (Campbell,
1969? 1976). Measurements were carried out in the antenatal clinic by
a specially trained midwife or obstetrician using a real-time ultrasound
scanner (System 85, Diagnostic Sonar, Livingstone, Scotland). When a
discrepancy was found between ultrasound and clinical assessments of
gestational age, the examination was repeated with a conventional static
scanner in the diagnostic ultrasound department, and the result accepted
as the definite indicator of gestational age. As a practical guide
"discrepancy" was defined as a difference of more than one week at 6 to
15 weeks of pregnancy, more than one and a half weeks at 16 to 23 weeks,
and more than two weeks at 24 to 28 weeks. If the patient was unsure
of the date of the start of her last menstrual period or if other
factors existed to make clinical assessment unreliable, the ultrasound
assessment was always accepted as definitive. The mean gestational
age at the time of this first-stage ultrasound examination was 15 weeks;
34% of the examinations were carried out before 14 weeks, 91% before 20
weeks, and all before 28 weeks.
Figure 3 - 1
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Ultrasonogram showing transverse section of fetal head.
SP : Septum pellucidum.
Figure 3-2
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Ultrasonogram showing transverse section of fetal trunk.
UV : umbilical vein; S : fetal spine
Figure 3-3
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Ultrasonogram showing longitudinal section of fetus
from which crown-rump length (CRL) is measured.
B : fetal bladder; H : fetal head.
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it was planned that all second-stage examinations would be performed
at between 34 and 36 weeks. Because, however, many patients had been
asked to return to the antenatal clinic around 36 weeks and would not
have been included in the study by strict adherence to this time period,
the examinations were carried out between 238 days (34 weeks) and 255
days (36 weeks 3 days). The following fetal dimensions were measured :
biparietal diameter (BPD), head area (HA), head circumference (HC),
transverse trunk diameter (TTD), trunk area (TA), trunk circumference
(TC), and crown-rump length (CRL). The BPD was measured by the combined
A and B mode technique described by Campbell (1968); HA and HC were
measured from a transverse ellipsoid section of the fetal head
displaying a central midline echo (Falx cerebri) with a short double
echo (septum pellucidum) one-third of the distance from the sinciput
(Campbell and Thorns, 1977) Figure 3-1). Area, circumference and
transverse diameter of the trunk were measured on a transverse section
of the fetal trunk at right angles to the long axis of the aorta and
displaying a short segment of umbilical vein (Campbell and Wilkin,
1975; Hansmann, 1977) Figure 3-2). The TTD was measured on the
bistable display using electronic calipers calibrated to a velocity of
1600 m/s. CRL was measured on a longitudinal section of the fetus
that included both the fetal bladder and the maximum area of the fetal
head (Wittmann et al., 1979) (Figure 3-3); no allowance was made
for flexion of the fetal trunk. A semi-automated electronic measuring
device (page 43) was used for accurate and rapid measurement (direct
from the grey-scale image) of area and circumference parameters and
CRL (Fleming et al., 1978). All measurements were carried out by the
author using a conventional static scanner (Diasonograph 4102,Nuclear
Enterprises, Edinburgh). In 57 cases (12%) satisfactory head measure¬
ments could not be obtained, either because the fetal head was in a
direct occipito-anterior or occipito-posterior position, or because it
was low in the maternal pelvis. TA and TC were measured in all cases,
as was CRL, a low fetal head being no obstacle to accurate measurement
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Histogram showing the birthweight distribution of the
study babies (shaded columns) compared with that expected
from the Aberdeen data (white columns).
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After delivery the measured parameters were analysed, singly and
in combination, to identify the optimal index for detecting small-
for-dates fetuses. To this end, measurement and other relevant data
were placed on computer cards. Nomograms were constructed by plotting
for each parameter the measurements obtained from the babies of normal
birthweight - that is, above the 5th percentile - against gestational age
at the time of examination. Median, 10th and 90th percentile curves
were constructed by plotting the appropriate values for each of the
eight consecutive two-day periods between 258 and 255 days, and a
smoothed percentile curve was obtained by carrying out a weighted
least-squares analysis of the logarithms of the percentiles against
time (the appropriate weights being the number of observations of the
parameter in the relevant two-day period). Measurements obtained from
the small-for-dates fetuses were then plotted and false-negative and
false-positive rates calculated for each parameter, the 10th percentile
curve on the nomograms being used as an arbitrary demarcation line for
identifying small-for-dates fetuses. A false-positive result was
recorded when the birthweight was normal though the measurement was
below the 10th percentile curve, and a false-negative result recorded
when the ba,by was small-for-dates though the measurement was above
this demarcation line.
RESULTS
The birthweight distribution of the 474 babies is shown in Figure
5-4; 56 infants (7.6%) had birthweights on or below the 5th percentile
of the Aberdeen chart (Thomson et al., 1968) and these were classified
as small-for-dates. The mean birthweight in this group was 2.51 kg
(range 1.20 - 2.77 kg) and it included two stillborn infants (both
fresh), one of whom was the only malformed infant in the study (renal
agenesis). The other infant died during an unsupervised vaginal breech
delivery at home, the mother having declined hospitalisation. Of the
56 small-for-da.tes fetuses, 18 had not been suspected clinically as
small-for-dates at any time, 17 were identified by abdominal palpation
as small-for-dates, and in one case elective serial biparietal
cephalometry provided evidence of growth retardation despite a clinical





Crown-rump length measurements obtained from those fetuses that
were small-for-dates at birth, plotted against gestational age
at the time of measurement.





Trunk area measurements obtained from those fetuses that
were small-for—dates at birth, plotted against gestational
age at the time of measurement. The encircled dot
represents the fetus with renal agenesis.
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Figure 3-7
C.R.L. x T.A. (cm3)
Gestational age (Days)
Product of crown-rump length and trunk area (CRL X TA) :
measurements obtained from those fetuses that were small-
for-dates at birth, plotted against gestational age at the
time of measurement. The 10th percentile curve is used
as the demarcation line.
Prediction of babies that were small-for-dates at birth, by
measurement of the different fetal parameters at second-stage examination
are shown in Tables 3 - 2a and 3 - 2b. Head measurements (BPD, HA, HC)
were insensitive screening examinations since they identified only
56 - 59 % of such babies. In contrast, measurement of the trunk
parameters TA and TC correctly identified 81 % and 83 % respectively,
although TTD with a sensitivity of 61 % was no more useful than the
head measurements. Area and circumference measurements were extremely
highly correlated with correlation coefficents between HA and HC and
between TA and TC of, respectively, 0.994 and 0.995, and this is
reflected in virtually identical efficacies. Similarly, the multi¬
plication of TA and TC by CRL provided equivalently effective indices:
the product of CRL and TA had a sensitivity of 94 % and specificity of
88 %; with the product of CRL and TC the sensitivity was 89 % and
specificity 91 %.
As will be discussed later, the product of CRL and TA (CRL X TA)
was selected for further study. The values obtained on small-for-dates
fetuses with CRL, TA and CRL X TA measurements are demonstrated on
Figures 3-5, 3-6 and 3-7; only two of the 36 affected fetuses
were not identified by CRL X TA measurement. The false-positive rate
obtained with this index was 12 % and the birth weight distribution of
these 52 babies of normal birthweight is shown in Table 3 - 2c.
The ratio of HA to TA (Varma et al, 1979) gave a high false-
negative rate.
TABLE 3 - 2a
PREDICTION OF BABIES THAT ARE SMALL-FOR-DATES (SFD) OR APPROPRIATE-












BPD 33 19 14 380 342 38
HA 33 19 14 381 342 38
HC 33 18 15 381 351 30
TA 36 29 7 438 390 48
TC 36 30 6 438 394 44
TTD 30 18 12 372 327 45
CRL 36 25 11 438 385 53
CRL x TA 36 34 2 438 385 52
CRL x TC 36 32 4 438 399 39
HA/TA 33 15 18 381 347 34
[In some cases, head measurements or TTD could not be measured due
to fetal position]
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TABLE 3 - 2b
SENSITIVITY, SPECIFICITY AND PREDICTIVE VALUES OF DIFFERENT
POSSIBLE SCREENING EXAMINATIONS.
Predictive Value Predictive Value
Sensitivity Specificity Positive Result Negative Result
Parameter % % % %
BPD 58 90 33 96
HA 59 90 33 96
HC 56 92 38 96
TA 81 89 38 98
TC 83 90 41 99
TTD 61 88 29 96
CRL 69 88 32 97
CRL x TA 9*1 88 39 99
CRL x TC 89 91 45 99
HA/TA 44 91 31 95
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TABLE 3 - 2c
BIRTHWEIGHT DISTRIBUTION OF BABIES WITH CRL x TA VALUES
BELOW THE 10th CENTILE.
Birthweight
< 5 %
5 - 10 %
10 - 25 %
25 - 50 %
50 - 75 %
75 - 90 %















The aim of this study was the development of a procedure suitable
for routine screening for small-for-dates fetuses and these have been
defined as having a birthweight for gestational age, on or below the
5th percentile according to the charts of Thomson et al. (1968), which
were based on the birthweights of over 52,000 infants born in Aberdeen
between 1948 and 19&4. These charts were chosen because of the
extensive nature of the Aberdeen study and also because of the
geographical proximity of Aberdeen to Glasgow. There are, however,
socio-economic and population differences between these two Scottish
cities and, since completion and analysis of the studies reported in
this thesis, birthweight for gestational age standards have been
reported for the Glasgow population (Forbes and Smalls, 1983)•
Comparison of the Aberdeen and Glasgow birthweight values at the 5"tb
percentile is shown in Table 3 - 3> the differences were greater for
pre-term births and the average difference from 37 weeks, when the
large majority of infants in the study reported here were delivered,
was only 40 g. Various workers have used different criteria to define
the small-for-dates infant; these have included 10th and 5tb percentiles
and minus two standard deviations from the mean. The 5th percentile
was chosen for this study both because it corresponds to the criteria
used by Campbell who has carried out the most important innovative
research into ultrasound assessment of fetal growth, and also because
it includes those fetuses most at risk from intrauterine growth
retardation. Thus Dobson et al (1981), in a study of 500 infants with
birthweights less than the 10th percentile, found the perinatal mortality
rate among those with birthweights less than the 5th percentile to be
190/1000; those with birthweights less than the 10th percentile but
greater than the 5th percentile had a perinatal mortality rate of
22/1000, and controls of normal birthweight had a rate of 11/100. The
latter two figures were not statistically different.
In the study reported here, sex and parity (Thomson et al,,1968)
were not taken into account in making the diagnosis of small-for-dates.
The lower average birthweight in first pregnancies, compared with
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TABLE $-5
COMPARISON OF BIRTHWEIGHTS AT THE 5TH PERCENTILE BETWEEN
ABERDEEN AND GLASGOW POPULATIONS, FROM 52 TO 42 WEEKS.
* **













(Data from Thomson et al. (1968) and Forbes and Smalls (1983)
second and subsequent pregnancies, must be assumed to be due to an
environmental restriction of fetal growth and unless this is proved
to be innocuous (and perinatal mortality rates are higher in first
than second pregnancies) it is illogical to make allowances for parity
in studies such as this. The same applies to maternal height and
weight, corrections advocated by Tanner and Thomson (1970). The
possible reasons why male infants are heavier than females have been
discussed in Chapter 1, and this does not seem to result in increased
risk to female infants. However, if sex is taken into account to
define small-for-dates this would require, for the sake of consistency
separate ultrasound growth charts, and ultrasound values could not be
evaluated because fetal sex is unknown, before delivery, in the large
majority of pregnancies. For these reasons and for the sake of
simplicity, small-for-dates infants have been defined by birthweight
on or below the 5th percentile for gestational age without "correction
for sex, parity, maternal height and weight.
The screening procedure described in this study comprises a two-
stage ultrasound examination schedule, an accurate knowledge of
gestational age being essential to permit interpretation of the
second-stage examination result because major errors may occur in the
clinical estimation of gestational age, even in the first trimester
(Beazley and Underhill, 1970). In the Queen Mother's Hospital, the
first-stage examination is incorporated into a routine policy of
carrying out ultrasound examinations on all patients at their first
attendance at the antenatal clinic when assessment of gestational age
is most accurate. Additional advantages of this policy include
detection of multiple pregnancies, non-viable pregnancies and some
fetal abnormalities (Neilson and Hood, 1980). Real-time ultrasound
scanners have been shown to allow accurate measurement of CRL during
the first trimester (Adam et al., 1979) and of BPD during the second
trimester (Adam et al., 1978; Osinusi et al., 1980), and, using
these equipments, the procedure may be easily assimilated into the
smooth running of the antenatal clinic.
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The timing of the second-stage examination at 34 to 36 weeks also
requires comment. At any gestational age, fetuses of similar size may
be growing, and thereafter continue to grow, at different rates.
Hence, if any ultrasound measurement has validity as an index of fetal
size its accuracy in predicting birthweight and identifying small-for-
dates fetuses increases as the time interval between measurement and
delivery decreases; this is logical and it has been substantiated on
prospective study by Wittman et al (1979). Thus, the sensitivity of
detection of small-for-dates fetuses would be expected to be greater
at, for example, 40 weeks than 30 weeks. However, the clinical value
of this information decreases as pregnancy advances because at each
week of pregnancy intrauterine deaths accumulate as a result of fetal
growth retardation and increasingly less time is available for
institution of tests of fetal wellbeing among the rest. The time
period of 34 to 36 weeks, chosen for this study, represents a compromise
between efficiency in detecting small-for-dates fetuses and the use¬
fulness of the information provided. As discussed earlier, Usher and
McLean (1974) have estimated that 7C% of perinatal deaths associated
with fetal growth retardation in Montreal could be avoided by accurate
identification of small-for-dates fetuses at 34 weeks, and Mcllwaine et
al. (1979) found that 45% of intrauterine deaths associated with fetal
growth retardation in Scotland occurred after 36 weeks. Another point
of relevance is that neonatal mortality among small-for-dates infants
decreases enormously as pregnancy advances; Lubchenco et al. (1972)
found that while the neonatal mortality rate of infants born at 32
weeks and weighing between 1000 g and 1250 g was 400/1000, that of the
equivalent small-for-dates group at 38 weeks (2000 g to 2250 g) was
40/1000, ten-fold less. The combination of fetal growth retardation
and prematurity is associated with high neonatal mortality; small-for-
dates infants born in good condition at term do well and it is some of
these infants which will be missed by screening earlier than 34 weeks.
Wittmann et al. (1979) found that measurement of CRL X TA between 32
and 34 weeks correctly identified only 8 of 14 small-for-dates fetuses
(57%); between 34 and 38 weeks, 10 of 12 (83%) were detected.
In the study described here, the head measurements were generally
less efficient as second-stage parameters than were the trunk measure¬
ments, reflecting the brain-sparing effect in which brain weight is
relatively less diminished than liver weight in small-for-dates
fetuses (Gruenwald, 197*0. TTD, however, was less efficient than the
other trunk measurements; in small-for-dates fetuses the transverse
trunk section is often distorted from the usual near-circular shape
and may be elongated in either the anteroposterior or transverse plane.
With transverse elongation of the trunk the diameter may be within
normal limits despite reduced TA and TC.
Slightly higher sensitivities were obtained by the product of
CRL and TA or TC than by measurement of the trunk parameters alone,
although, because of the relatively small number of small-for-dates
babies in this study, no meaningful formal statistical evaluation
could be made of the relative efficacies. Small-for-dates infants
have shorter body lengths (Usher and McLean, 197*0 and measurement
of the direct CRL is also of value in aiding detection of the hyperflexed
small-for-dates fetus. In addition, flexion on the fetal trunk not only
decreases the measured CRL, but probably also increases the dimensions
of the measured transverse section, so that a combination of length and
cross-sectional area provides a better assessment of fetal size. Little
and Campbell (1982) have criticised, on theoretical grounds, CRL measure¬
ment as performed in this study - that it is "unphysiological" because
it does not represent the true fetal crown-rump length, and that the
exact point at which the rump ends is often poorly defined because
of maternal bowel gas overlying the fundus of the uterus or the apposition
of the rump to the uterine wall or placenta. In reply, it may be said
that the aim of the study was not the assessment of physiological growth
of the fetus, but the development of a practical means of screening for
the small-for-dates fetus. Measurement of true crown-rump length would
take longer (a practical disadvantage) and would appear to have
theoretical disadvantages in aiding detection of the small-for-dates
fetus, as outlined above. The different acoustic characteristics of
fetal tissue on one hand and placenta and uterus on the other means that
the end point of the rump may be readily detected; overlying maternal
bowel gas does not pose a practical problem in the experience of the
author who has found the only situation where definition of the rump
may be difficult, is when the fetal hips are extended, and this is rare.
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The 10th percentile curve for each parameter measured on normally
grown fetuses was chosen arbitrarily as a means of comparing the use¬
fulness of the different parameters, and as a possibly useful demarca¬
tion line bearing in mind the excessive presence of babies of lower
birth weight as a result of the selection of subjects. As a means
for detecting the small-for-dates fetus, the demarcation line need not
have been a percentile curve and it would have been quite justifiable
to have drawn a suitable demarcation line with a ruler at the completion
of the study. Although the 10th percentile curve was calculated and
plotted in identical fashion for each parameter, there was some small
variation in the false-positive rate as a result of differing distribu¬
tions of values. In this context, false-negative and false-positive
results should not be given equal weight. The author is in agreement
with Stempel (1982) that in any procedure which is advocated as a means
for detecting the small-for-dates fetus, false-negative results are of
greater significance than false-positive results. Intervention is
planned predominantly on the results of tests of fetal wellbeing and
normally grown fetuses in good condition but with low ultrasound values
may thus be managed conservatively. On the other hand, the false
reassurance that a small-for-dates fetus is of normal size leads to
obvious dangers. This is in contrast to, for example, a prenatal
test to detect a lethal fetal abnormality with which it is vital to
avoid false-positive reports, even at the cost of diminished sensitivity,
so that normal fetuses are not, in consequence, aborted. The clinical
context and therapeutic implications are of cardinal concern in
balancing optimal sensitivity against specificity for any diagnostic
test.
Of the several measurements which effectively identified small-
for-dates fetuses, CRL x TA was selected for further study. Area
measurement is theoretically more accurate than circumference measure¬
ment using the particular equipment utilised for these studies,
(Fleming et al, 1978) - on electronic'tracing" of the outline of a
fetal section, the trace will inevitably deviate from the actual
outline; if, for each sector measured, the trace equally deviates
within and without the boundaries, area measurement will be accurate
whereas circumference will be overestimated. This is probably only
of theoretical concern, however, because (as described earlier) TA
and/
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and TC were found to be extremely highly correlated (r = 0.995) and
the efficacies of CRL x TA and of CRL x TC on one hand, and of TA and
of TC on the other, were virtually identical.
CRL x TA was preferred to TA alone because of its possibly
increased sensitivity. Despite the disadvantage of performing
two rather than one measurement, in the author's hands, using the
semi-automated area and perimeter device, the entire procedure, including
plotting of the result and explanation to the mother, took about four
minutes. It was thus logistically suitable as a screening procedure.
The efficacy of CRL x TA measurement did, however, require prospective
assessment, and studies designed to evaluate this are described in the
following two chapters. The 12% false-positive rate found in this study
must not be ignored since an erroneous diagnosis that the fetus is
small-for-dates may lead occasionally to inappropriate intervention;
Chapter 4 describes a prospective randomised controlled trial to assess
the possible positive or negative effects on fetal outcome and obstetric
management of instituting this screening programme in low-risk patients.
With a sensitivity of 94%, specificity of 88% and predictive value
of 39%, the 10th percentile curve calculated for CRL x TA proved so
suitable that analysis of alternative demarcation lines appeared super¬
fluous.
CHAPTER 4.
SCREENING FOR THE SMALL-FOR-DATES FETUS:
A PROSPECTIVE RANDOMISED CONTROLLED TRIAL
79«
INTRODUCTION
The study reported in the preceding chapter showed that the two-
stage ultrasound examination schedule, comprising assessment of
gestational age in early pregnancy followed by measurement of the
product of crown-rump length and trunk area (CRL X TA) at 34 to 3&
weeks, appeared highly effective in the detection of the small-for-
dates fetus and seemed suitable as a screening procedure. The study
reported in this chapter describes the use of this schedule in a group
of patients not thought to be at high risk of producing a small-for-
dates infant. The aims of the study were two-fold:
(i) to evaluate prospectively the efficacy of CRL X TA
measurement in detecting small-for-dates fetuses;
(ii) to assess the impact on fetal outcome and obstetric
management of instituting the two-stage schedule in
"low-risk" mothers.
On the first point, the preceding chapter described how the seven
fetal parameters, measured at 34 to 36 weeks, were evaluated as
indices of fetal growth retardation at the completion of the study.
It is obvious that the results of CRL X TA measurement obtained thus,
may not necessarily correspond to those found on prospective study.
The second aim addresses the question of whether, assuming CRL X TA
measurement is confirmed to be effective, this screening procedure
leads to an improvement in fetal outcome and, if so, whether this is
to such an extent that it justifies implementation as a routine. The
facts that small-for-dates fetuses demonstrate high perinatal mortality
and morbidity, and that CRL X TA measurement appears highly effective
in detecting such fetuses, do not necessarily mean that introduction
of routine measurement would be advantageous. Should the outcome for
small-for-dates fetuses be improved, this could, for example, be out¬
weighed by the effects of inappropriate intervention in pregnancies
in which a false-positive diagnosis of growth retardation had been made.
Many techniques of fetal assessment were introduced into obstetric
practice during the 1960*s and 1970's but none were evaluated by means
of prospective randomised controlled trials prior to their introduction.
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Of those that have now been so evaluated, e.g. oestrogen (Duenhoelter
et al. 1975) and HPL (Spellacy et al., 1975) assay, antepartum cardio-
tocography (Brown et al., 1982; Flynn et al., 1982) and continuous
fetal heart rate monitoring during- labour (Renou et al., 1976; Kelso
et al., 1978; Haverchamp et al., 1979)» assessment was not made until
after these techniques already enjoyed a well established place in
obstetric practice. Under such circumstances assessment becomes more
difficult for "ethical" and practical reasons, and the rationalisation
of the use of a procedure already accepted in clinical practice is
often impossible. Chalmers et al. (1976a), in a retrospective study
in Cardiff, were unable to demonstrate any difference in perinatal
mortality and morbidity between two obstetric teams, only one of which
enthusiastically employed oestriol assays and ultrasonic biparietal
cephalometry in fetal assessment. To quote these workers:
"suggestions that either urinary oestrogen assay or serial
ultrasound cephalometry will only pay perinatal dividends
when total population screening is employed must be
evaluated in exactly the same way as their use in a
selected population - by controlled trial .... Our own
research has shown us that we are in urgent need of
experimentally-derived information with which to plan a
rational deployment of our limited resources."
(Chalmers et al., 1976b).
The results of carrying out CRL X TA measurement were assessed, in
the study reported here, by means of a prospective randomised controlled
trial. Only low risk patients were studied because:
(i) approximately half of small-for-dates infants are born
to these mothers,
(ii) non-clinical techniques of fetal assessment are not,
currently, applied in these pregnancies to aid detection
of the small-for-dates fetus,
(iii) it would be unethical and impractical to attempt to
withhold relevant information in high-risk pregnancies
where concern about fetal wellbeing pre-existed.
PATIENTS AND METHODS
The study was carried out between May 1979 and January 1981. Suitable
subjects were identified by the inspection of case records on the day
prior to each hospital antenatal clinic. Patients whose pregnancies had
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advanced to between 238 days (34 weeks) and 255 days (36 weeks 3 days)
gestational age at the time of antenatal clinic attendance, and who
did not fall into any of the exclusion categories listed below, were
asked to participate in the study. The format of the study had been
approved by the hospital ethical committee and informed consent was
obtained from each subject. Whilst no formal record was kept of the
number of patients who declined to participate in the study, it is
estimated that approximately 90% of those asked, participated. Ultra¬
sound examination was performed immediately after antenatal clinic
attendance.
Deliberate exclusions from the trial will be discussed along with
reasons why suitable patients were not requested to participate:
(i) Uncertain gestational age
Because of the uncertainties associated with clinical
assessment of gestational age, it was thought vital to
carry out ultrasound examination in early pregnancy to
accurately pin-point gestational age as a reference point
for interpretation of CRL X TA measurement. This first-
stage examination was performed on all patients when they
first attended the antenatal clinic, gestational age being
assessed by measurement of the fetal crown-rump length up
to 14 weeks (Robinson, 1973) and of the biparietal diameter
after 13 weeks (Campbell, 1969; 1976). When a discrepancy
existed between clinical and (repeated) ultrasound assessment
of gestational age, the ultrasound dates were accepted (see
Chapter 3)- As discussed earlier, the accuracy of ultra¬
sound measurement as an index of gestational age decreases
as pregnancy advances. For the purposes of this study, 24
weeks were regarded as the maximum gestational age at which
ultrasound examination was of sufficient accuracy to con¬
stitute the first-stage examination. Patients who, through
late attendance at the antenatal clinic, did not undergo
ultrasound examination before 24 weeks, were ineligable for
inclusion in the study.
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) High-risk patients
Patients deemed to be at high risk of producing a small-for
dates infant were excluded. The decision of the relevant
clinical staff as to which of their patients were high risk
was accepted. Thus were excluded:
(a) any patient in whom biochemical and/or biophysical
(including ultrasound) monitoring had been initiated
because of an unfavourable previous reproductive history
or the development of complications during the current
pregnancy;
(b) any patient in whom clinical suspicion of fetal growth
retardation had already been recorded,
(c) any patient for whom the clinical staff had requested
the results of CRL X TA measurement on the day of the
second-stage examination.
) Multiple pregnancies
Multiple pregnancy is associated with a high perinatal mortality
rate (Mcllwaine et al., 1979b) and a high incidence of fetal
growth retardation (Manlan and Scott, 1978). Patients with
multiple pregnancy should be regarded as being at high risk of
producing small-for-dates infants and they were, therefore,
excluded from this study. The use of CRL X TA measurement in
twin pregnancies was, however, evaluated separately and the
results are presented in Chapter 6.
) Peripheral clinic patients
There are six antenatal clinics held each week in the Queen
Mother's Hospital. An additional two antenatal clinics,
staffed by hospital obstetricians, are held in a large housing
estate on the outskirts of Glasgow, Drumchapel. Patients who
attend the Drumchapel clinics (13% of the total) are delivered
in the Queen Mother's Hospital but all normal aspects of ante¬
natal care (including early ultrasound examination) are per¬
formed at the local clinic. For practical and financial reasons
it was not thought reasonable to ask these patients to travel
8%
to the hospital for participation in the study. It is
however, worthy of note that the Drumchapel population
contains a higher proportion of women of social classes
4 and 5, and produces a higher proportion of small-for-
da.tes infants than the population attending the antenatal
clinics at the hospital. (Ridley : personal communication),
(v) Failure of attendance at 34 to J>6 weeks
There is no rigid scheme of timing visits to the antenatal
clinics; some patients were not asked to attend at a time
when they would have been within the screening period of
34 to 36 weeks, and they were therefore ineligible for
inclusion in the study as were patients who defaulted
from attendance at the relevant time.
(vi) Miscellaneous
(a) As discussed previously, patients were under no obligation
to participate in the study and some declined to do so.
(b) On several occasions either the static ultrasound scanner
(which was rather old) or the electronic area and
perimeter measuring device ceased to function leading to
the cancellation of study sessions.
(c) Clinical and other commitments (including holidays) of
the author and his collaborator meant that not all
available sessions were utilised.
The study group comprised 879 patients. All had undergone first-
stage ultrasound examination before 24 weeks (mean 14.0 weeks S.D. 3.1)•
At the time of entry into the study all had apparently normal singleton
pregnancies without clinical evidence of fetal growth retardation. At
the time of second-stage ultrasound examination at 34 to 36 weeks,
subjects were randomly allocated to one of two groups according to
whether the last digit of their hospital number was odd or even (this
was alternated monthly). In both groups fetal CRL and TA were measured
by the technique described in Chapter 3. In group 1 subjects (reported
group), the product CRL XTA was calculated, the best assessment of gesta¬
tional age was made, the CRL X TA value was plotted on the chart obtained
from the Chapter 3 study, and the chart inserted into the case-notes.
To ensure that the clinical staff were aware that their patient had
been included in the study, the antenatal sheet was prominently
stamped with the words "IUGR Study", and a written interpretation of
the CRL X TA value was included on the ultrasound report sheet in the
case-notes. If the CRL X TA value fell on or below the demarcation
line (the 10th percentile curve), the written report indicated that
"this may represent fetal growth retardation", and arrangements were
made for the patient to return to the antenatal clinic the following
week (if not previously so arranged). In some such cases repeated
CRL X TA measurement was performed at that time. Otherwise subsequent
management and fetal monitoring were left entirely to the clinical
staff.
In group 2 patients (non-reported group), the CRL and TA were
recorded on project sheets, without calculation of the product or
interpretation of the results. The antenatal sheet was stamped as
in group 1, and the ultrasound report sheet was stamped "not reported".
There were, thus, two groups of subjects - those in whom the CRL X TA
values were reported to the clinical staff, and those in whom the
clinical staff were unaware of the CRL X TA value. All second-stage
ultrasound examinations were performed by the author or by Dr. S.P.
Munjanja.
Whilst there is no uniformity of opinion as to which factors are
significantly associated with fetal growth retardation (McKeown and
Gibson, 1951; Love and Kinch, 19&5; Scott and Usher, 1966; Hedberg
and Holmdahl, 1970; Galbraith et al., 1979)» those characteristics
that have been described as important were recorded during the study;
these included maternal age, height and weight, parity, cigarette
consumption, social class and race. Many of these factors also
correlate with overall perinatal mortality (Baird, 19^3> Mcllwaine
et al., 1979)• Also recorded were the subsequent development of
pregnancy complications such as hypertension and antepartum haemorrhage,
and the consequent need for admission to hospital. Details of delivery
and the sex, birthweight and condition at birth of the babies were also
recorded. Condition at birth was assessed by the scoring system of Apgar
(Apgar and James, 19&2) at one and five minutes. Whilst accepting
that the correlation between Apgar score and metabolic acidosis is
not good (Sykes et al., 1982), it was felt that Apgar scoring was
sufficiently sensitive for the purposes of this study. Although
almost all patients underwent continuous fetal heart rate monitoring
during labour, no attempt was made to calculate the incidence of
fetal distress during labour because of disparity of opinion as to
what constitutes fetal distress (Steer, 1982) and how it should be
managed. What is more important than the author retrospectively
analysing intrapartum cardiotocographic traces, is the reaction of
the clinical staff to the traces within the whole clinical setting
of the patient in labour.
In several cases there had been incomplete documentation of data
in the case-notes (e.g. maternal height had not been recorded). In
others the case-notes were missing at the time of analysis of outcome
and in these patients the Labour Ward records were used. These pro¬
vided most but not all of the required information and this accounts
for the small inconsistencies in some of the tabulated numbers.
Data on group characteristics and on fetal outcome and obstetric
management were recorded on computer cards, and statistical evaluation
was performed using the Statistical Package for the Social Sciences
(SPSS). The two statistical tests used to examine inter-group
differences were the chi-squared test and the t test for independant
samples. The former was used when the data was categorical in nature;
the latter was employed when the data displayed an interval level of
measurement and when the variances of the samples did not differ
significantly. When the F ratio test indicated a significant difference
in the variances, a modified form of the t test, in which sample variance
was separately estimated, was used (see SPSS manual).
The characteristics of both groups of subjects are shown and compared
in Table 4-1; the only significant inter-group difference was in
social class distribution (x^ 11.74, 4df, P<_0.05) with more social
class 5 patients in the reported group. It is particularly difficult
to identify those nulliparous patients who are at high risk of
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TABLE 4 - 1
CHARACTERISTICS OF SUBJECTS GROUPED ACCORDING TO WHETHER THE
CRL X TA VALUE WAS REPORTED (GROUP 1) OR NOT (GROUP 2).
Where appropriate mean values and one standard deviation, or numbers and
percentages are tabulated.
Statistical comparison between the two groups was by X or t tests.
(N.S. = no significant difference).
1. Number
2. Maternal Age (yrs)
3. Maternal Height (cms)
4. Maternal Weight (34-36 weeks)(kg)



































12. Gestational Age 1st-stage
ultrasound (weeks)
13. Serum APP: Normal
High

































































































































producing a small-for-dates infant because reproductive performance is
unknown (Adelstein and Fedrick, 1978; Galbraith et al., 1979); the
characteristics of the nulliparous subjects in both groups were there¬
fore further compared (Table 4-2). This analysis showed that the
difference in social class distribution was confined to parous subjects
(x^ 13.29, 4 df, p^O.01) but among the nulliparas, there was a
significant difference in fetal presentation at the time of second-
stage ultrasound examination (x^ 4«74» 1 df, p <!0.05) due to a
greater incidence of breech presentation in the non-reported group.
These sub-groups were otherwise similar.
The details of findings at second-stage examination are shown in
Table 4 - % On nine occasions clinically unsuspected breech presen¬
tation was identified at second-stage ultrasound examination. A
single case of unsuspected major placenta praevia was also discovered.
These findings were always reported to the clinical staff regardless
of to which group the patient had been allocated.
The clinical staff were entitled to obtain CRL X TA results of
Group 2 subjects if this appeared important at any time after measure¬
ment; this never occurred and there were no exclusions for this
reason. Two subjects from Group 1 were, however, excluded because
they delivered elsewhere; in both cases the CRL X TA value was normal.
Thus, in the study there were 877 singleton babies delivered. All
babies were liveborn although one very large infant (birthweight 5-32 kg)
in Group 1 had an Apgar scope of 0 at one minute following shoulder
dystocia, but was successfully resuscitated and has appeared normal at
paediatic follow-up. Those babies with birthweights equal to or less
than the 5th percentile of the Aberdeen chart (Thomson et al., 1968)
were classified as small-for-dates, and these numbered 33 (3.9%)«
There were two babies with major malformations, both from Group 2
mothers. One was an Amsterdam dwarf (Cornelia -de - Lange syndrome),
and the other a baby with open lumbar spina bifida and microcephaly.
The latter infant died as a neonate and this was the only perinatal
death in the study (perinatal mortality rate 1.1/1000). The diagnosis
of microcephaly was suspected at second-stage examination; this
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TABLE 4-2
CHARACTERISTICS OF NULLIPAROUS SUBJECTS GROUPED ACCORDING TO WHETHER THE CRL X
TA VALUE WAS REPORTED (GROUP 1) OR NOT GROUP 2). Median values and one standard
deviation, or numbers and percentage are tabulated where appropriate. Statistical
comparison was by x2 orttests. (N.S. = no significant difference).
GROUP 1 GROUP 2
(REPORTED) (NOT REPORTED)
1. Number 190 178
2. Maternal Age (yrs) 24.9 (SD 4.3) 25.2 (SD 4.5) N.S.
3. Maternal Height (cms) 160.5 (SD 5.9) 160.2 (SD 5.8) N.S.
4. Maternal Weight (54-36 wks) (kg) 68.5 (SD 9.0) 68.9 (SD 9.0) N.S.
5. Social Class I 13 ( 7%) 18 (10%) N.S.
II 54 (29%) 41 (23%)
III 61 (32%) 68 (38%)
IV 34 (18%) 34 (19°%)
V 26 (14%) 17 (10%)
6. Race White 180 (95%) 174 (98%) N.S.
Other 10 ( 5%) 4 ( 2%)
7. Smoking None 144 (76%) 123 (70%) N.S.
< 1O/Day 18 (10°%) 15 ( 9°%)
10 - 2O/Day 23 (12%) 25 (14%)
> 2O/Day 5 ( 3%) 14 ( 8%)
8. Blood Group 0 98 (52%) 101 (57%) N.S.
A 67 (36%) 51 (29%)
B 19 (10%) 17 (10%)
AB 4 ( 2%) 8 ( 4%)
9. Consultant 1 30 (16%) 43 (24%) N.S.
2 27 (14%) 24 (14%)
3 40 (21%) 35 (20°%)
4 35 (18%) 38 (21%)
5 35 (18%) 19 (10%)
6 23 (12%) 19 (10%)
10. Gestational Age 1st-stage
ultrasound (wks) 14.3 (SD 3.2) 14.0 (SD 3.0) N.S.
11. Serum Alpha-feto protein: Normal 167 145 N.S.
High 1 1
12. 2nd Trimester Amniocentesis 4 ( 2°%) 3 ( 2%) N.S.
13. Gestational Age 2nd-stage
ultrasound (days) 247.2 (SD 5.4) 246 (SD 5.8) N.S.
14. Presentation 2nd-stage
ultrasound Cephalic 184 (97%) 163 (92%) P < 0.05
Other 6 ( 3%) 15 ( 8%)
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TABLE 4-3








Gestational Age (days) 247.1 (SD 5.4) 246.8 (SD 5.6)











suspicion was not reported to the clinical staff. Less major
congenital anomalies among the other babies were single cases of
cleft palate (Group 1), pyloric stenosis, congenital adrenal hyper¬
plasia and congenital dislocation of hips (Group 2). All malformed
babies were of normal birthweight.
CEL X TA values on or below the 10th percentile were classified
as abnormal. In a few cases in Group 1 when the CRL X TA value was
found to be abnormal, measurement was repeated one week later and
aga.in reported to the clinical staff. These latter measurements
were not included in calculation of sensitivity and specificity, but
are described later.
RESULTS
The results of the study will be discussed in two parts: the
accuracy of CRL X TA measurement in detecting small-for-dates fetuses,
and the impact on fetal outcome and obstetric management of
instituting CRL X TA measurement as a screening procedure in low-risk
pregnancies.
1. Efficacy of CRL X TA measurement
Of the 33 babies which were small-for-dates at birth, 31 (94%)
had CRL X TA values below the demarcation line (Figure 4 - 1)
resulting in a false-negative rate of 6%. The remaining 844
babies were of normal birthweight, and of these, 763 (90%) had
normal CRL X TA values. The birthweight distribution of the
false-positive cases is shown in Table 4-4; 21% had birth-
weights between the 5th and 10th percentiles. Overall the
results of CRL X TA measurement in this study may be summarised
as follows: sensitivity 94%» specificity 90% and predictive
value 28%. There was no significant difference in sensitivity,
specificity and predictive value between Groups 1 and 2 (Table
4 - 5).
Fourteen of the subjects in Group 1 who had abnormal CRL X TA
values underwent repeat measurement one week later and within the






















Product of crown-rump length and trunk area ! measurements
obtained from fetuses that were small-for-dates at birth
plotted against gestational age at the time of measurement.
The 10th percentile curve is used as the demarcation line.
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TABLE 4-4
DISTRIBUTION OF BIRTHWEIGHT AND PREDICTION OF OUTCOME BY CRL x TA
MEASUREMENT (BOTH GROUPS).
BIRTHWEIGHT N TRUE NEGATIVE FALSE POSITIVE TRUE POSITIVE
5% 53 31
5 - 10% 29 12 17
0 1 ru VJl •SR 128 94 34
25 - 50% 203 181 22
50 - 75% 256 248 8
75 -90% 153 153 0
90 - 95% 41 41 0
95% 34 34 0
877 763 81 31
FALSE NEGATIVI
TABLE 4-5
PREDICTION OF OUTCOME BY CRL x TA MEASUREMENT




PREDICTIVE VALUE 31% 24%
Sensitivity is the percentage of small-for-dates babies with abnormal CRL X TA
values; specificity the percentage of normal birthweight babies with normal
CRL X TA values; predictive value the percentage of babies with abnormal CRL X
TA values that were small-for-dates at birth.
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cases and the babies were all of normal birthweight; in four
cases repeat CRL X TA was again abnormal and three of these
babies were small-for-dates a.t birth. This suggests that the
false-positive rate may be reduced by repeat measurement.
The results of CRL X TA measurement were compared with those
of crown-rump length alone and of trunk area alone (Table 4-6).
2. Impact of CRL X TA measurement on outcome
Fetal outcome was assessed by recording perinatal death,
birthweight and Apgar Scores. Also recorded were aspects of
obstetric management which could have been influenced in either
a positive or negative fashion by the screening programme; these
included hospitalisation, rate of induction of labour, mode of
delivery and gestational age at delivery. To assess the effects
of CRL X TA measurement on outcome, all patients in Groups 1 and 2
were compared (Table 4-7) nulliparas in both groups were
compared separately (Table 4-8), and both small-for-da.tes sub¬
groups were compared (Table 4-9). Statistical analysis, as
before, used y? of t tests.
DISCUSSION
The hazards of fetal growth retardation make attractive a technique
for screening for the small-for-dates fetus. The sensitivity of 94%
and specificity of 9C% found in this prospective study confirm that
CRL X TA measurement is highly effective in detecting the small-for-
dates fetus. Alternative strategies and techniques designed to aid
detection of the small-for-dates fetus have been described in Chapter 1,
and CRL X TA measurement is much more effective than these. Comparison
with published reports of the value of alternative ultrasound techniques
poses difficulties because there are differences in the definition of
small-for-dates, in the selection of the populations studied, in the
timing of ultrasound examination and in deciding on a demarcation line
which provides the best pay-off between sensitivity and specificity.
However, comparison with the results of those of the studies described
in Chapter 2 which were large, prospective and of sound methodology,
TABLE 4-6
COMPARISON OF PRODUCT OF CROWN-RUMP LENGTH AND TRUNK AREA (CRL X TA).
CROWN-RUMP LENGTH (CEL), AND TRUNK AREA (TA) IN DETECTION OF
SMALL-FOR-DATES (SFD) FETUSES.
PARAMETER RATES (%)
Sensitivity False-negative Specificity Fale-positive
CRL 66 33 85 15
TA 79 21 88 12
CRL X TA 94 6 90 10
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TABLE 4-7
OBSTETRIC MANAGEMENT AND FETAL OUTCOME AFTER SECOND-STAGE ULTRASOUND EXAMINATION:
ALL SUBJECTS.




- days 1.0 (SD 0.2) 0.9 (SD 0.2)
- number 45 (10%) 46 (10%)
- reasons:
hypertension 52 (74%: 27 (59%)
antepartum haemorrhage 5 (12°%: 2 ( 4%)
variable lie 1 (2%; 8 (17%)
suspected growth retardation 5 (7%;I 5 11%)
other 2 (5%:l 4 ( 9%)




suspected growth retardation 12 9
other 28 52
Delivery
- gestational age (weeks) 59.5 (SD 1I.2) 59.5 (SD 1.2)
- mode:
spontaneous vertex 259 (6o%:I 281 (55%)
foreeps 107 (25%: 101 (25%)
Vacuum 15 (5%: 5 (1%
emergency Caesarean Section 57 (9%: 52 ( 7%)
elective Caesarean Section 17 (4%:I 24 ( 5%)
assisted breech delivery 0 1
Sex: female 220 (51%) 222 (50°%)
male 215 (49%) 222 (50%)
Birthweight (kgs) 5.45 (SD 0.5) 5.42 (SD 0.4)
Small-for-dates 17 (4%:I 16 ( 4%)
Apgar Score ( < 7 ):
- one minute 57 ( 9%) 40 (10%)
- five minutes 8 ( 2%) 5 ( 1%)
Stillbirths 0 0
Neonatal Deaths 0 1
96,
TABLE 4-6








- days 1.1 (SD 4.0) 1.2 (SD 3.6) N,
- number 25 (13%) 26 (15%:\ N,
- reasons:
hypertension 22 (88%) 19 (73%)
antepartum haemorrhage 1 1
variable lie 0 0
suspected growth retardation 1 3
other 1 3
Induction of Labour 59 (31%) 60 (34%) N.
- reasons:
post-term 25 (42%:i 23 (38°%)\ N
hypertension 23 (39%:i 26 (43%:
suspected growth retardation 4 (7%:i 4 ( 7%
other 7 (12%:i 7 (12%:
Delivery
- gestational age (weeks) 39.4 (S.D. 1.3) 39*5 (SD 1.3) N.S.
spontaneous vertex 75 (40%) 73 (41%) N.S
forceps 78 (41%) 71 (40%)
7 ( 4%) 4 ( 2%)
emergency Caesarean Section 25 03%) 22 (12%)
elective Caesarean Section 5 ( 5%) 8 (
Sex: female 105 (55%) 79 (44%) P<0.0
male 85 (45%) 99 (56%)
Birthweight (ks) 3.39 (SD 0.47) 3.35 (SD 0.44) N.S
Small-for-dates 9 ( 5%) 7 ( 4%) N.S
Apgar Score (*C.7)s
- one minute 17 (9%) 20 (11%) N.S
- five minutes 3 ( 2%) 3 ( 2%) N.S
Stillbirths 0 0
Neonatal Deaths 0 1
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TABLE 4-9
OBSTETRIC MANAGEMENT AMD FETAL OUTCOME AFTER SECOND-STAGE ULTRASOUND
EXAMINATION: BABIES SMALL-FOR-DATES AT BIRTH.




- days 3.1 (SD 1.7) 1.8 (SD 0.8) N.S.
- number 4 (24%) 4 (25%) N.S.
- reason:
hypertension 2 1
suspected growth retardation 2 3
Induction of labour 4 (24%) 7 (44%) N.S.
Birthweight (kg) 2.43 (SD 0.2) 2.45 (SD 0.2) N.S.
Delivery
- gestational age (weeks) 38.8 (SD 1.1) 39.5 (SD 1.5) N.S.
- mode:
spontaneous vertex delivery 11 (65%) 8 (50%) N.S.
operative delivery 6 (35%) 8 (50%)










As there was a significant difference in the variance of the samples,
a separate variance estimate was used in the calculation of the t
value (see SPSS Manual).
shows improved detection of small-for-dates fetuses by CRL X TA
measurement. The results of this study also confirm the value of
measuring CRL in addition to TA.
What, however, of the value of CRL X TA measurement in improving
fetal outcome or rationalising obstetric management in low risk
patients? This study was carried out between May 1979 January
1981. During the three years 1979 - 1981 there were 113 perinatal
deaths in the Queen Mother's Hospital, grouped in Table 4-10
according to local "Yorkhill Classification" (Whitfield : personal
communication) and, as can be seen, there were six deaths attributable
to fetal growth retardation in the absence of other complications and
of fetal deformity; only three of the deaths occurred after 34 weeks.
If there were to be any improvement in perinatal mortality among
small-for-dates fetuses as a result of CRL X TA measurement in low
risk patients it would require, to demonstrate it, the study of many
thousands of patients. CRL X TA measurement would be unlikely to
have an impact on other causes of perinatal death other than, perhaps,
a greater anticipation of the rare cases of shoulder dystocia in
fetuses with particularly large measurements.
Improvements that might have been observed within the scope of
this study would have been more subtle. Thus improved management of
the small-for-dates fetus might have resulted, with a greater use of
fetal monitoring and planned delivery leading to a decreased need for
operative delivery and to improved condition at birth. The reassurance
that a CRL X TA value was normal might have resulted in decreased rates
of induction of labour from 40 weeks.
The two groups (reported and non-reported) were well matched. The
one statistically significant difference, that of social class distri¬
bution, is unlikely to be important. The undoubted relationship between
social class and perinatal mortality rate and incidence of fetal growth
retardation probably operates through such factors as late attendance
at antenatal clinics, poor nutrition as evidenced by maternal height
and weight, smoking and high parity. Comparison of these factors and
also of the incidence of small-for-dates babies in both groups showed
TABLE 4-10




Unexplained intrauterine death 14
Hypertension 10
Antepartum Haemorrhage 8









Perinatal Mortality Rate 11.3/1000
(Whitfield 1983 * personal communication),
no difference. There was, likewise, no difference in outcome (Table
4 - 7). Rates of induction of labour were similar (and high in
keeping with the hospital induction rate at the time) as were mode of
delivery a.nd the Apgar Scoring and birthweight was the same. There
was a similar lack of effect in nulliparous sub-groups (Table 4-8).
The condition of the small-for-dates infants at birth was, in
general, good. None required resuscitation at birth and none
encountered major neonatal problems. Five of the 16 small-for-dates
fetuses in the non-reported group were identified as such by abdominal
palpation after second-stage ultrasound examination but prior to
delivery. There was no difference in outcome between the two small-
for-dates groups. (Table 4 - 9)«
To summarise the findings, there was no evidence that screening low
risk patients by CRL X TA measurement resulted in any advantage or
disadvantage as assessed by evaluation of fetal outcome or obstetric
management. The ultrasound examination of almost 900 patients took up
considerable machine and operator time and if no improvement could be
demonstrated with this size of sample it may be assumed that a screening
programme would not be a cost-effective and practical proposition. On
the basis of the findings in this study the two-stage ultrasound
examination schedule could not be recommended as a general screening
technique.
One of the factors that may have contributed to these negative
findings is the exclusion of the most disadvantaged group of women who
deliver in the Queen Mother's Hospital (those from Drumchapel).
Further, the fact that a study is being carried out in a hospital and
particularly one which is, in effect, evaluating missed diagnosis by
clinical staff, probably heightens awareness of the problem and
improves clinical detection rates. Whilst this is no bad thing, many
patients who were referred for CRL X TA measurement (details included
in Chapter 5) because of clinical suspicion that the fetus was small-
for-dates would probably not otherwise have been investigated and this
effect may have diluted the impact of CRL X TA measurement.
CHAPTER 5.
EVALUATION OP THE TWO-STAGE ULTRASOUND EXAMINATION
SCHEDULE IN HIGH RISK PREGNANCIES
102.
INTRODUCTION
The preceding chapter has confirmed that CRL X TA measurement is,
on prospective study, highly effective in detecting the small-for-
dates fetus among low risk pregnancies. CRL X TA measurement may
also be useful in the assessment of high risk pregnancies not only
because of its apparently high sensitivity but also because it need
only be measured on a single occasion during the third trimester.
A report is available at once in contrast to serial ultrasound
measurements which necessitate a time lapse before the fetal growth
retardation becomes apparent; further, for logistic reasons, a
single ultrasound examination allows the threshold for referral of
patients for ultrasound study to be lowered. The need for this has
been highlighted by a recent survey of perinatal deaths in the Mersey
region of a format similar to the national confidential inquiries
into maternal deaths (Mersey Region Working Party, 1982). This study
showed that of 182 perinatal deaths with avoidable factors, 13 were
due to a failure to detect small-for-dates fetuses despite associated
factors which should have prompted suspicion; in a further 7 cases
the fetus was diagnosed correctly as small-for-dates but appropriate
action was not then taken.
The study reported in this chapter evaluates prospectively the two-
stage ultrasound examination schedule in high risk pregnancies.
PATIENTS AND METHODS
The study group comprised 202 patients with singleton pregnancies,
referred for measurement of fetal CRL X TA at between 238 and 255
days because they were thought to be at high risk of producing small-
for-dates infants. All pa.tients had undergone first-stage ultrasound
examination to establish gestational age before 24 weeks (mean 14.4
weeks). Sixty-six (33%) were nulliparous. The main indications for
referral for second-stage ultrasound study during the third trimester
are shown in Table 5 - 15 Uy Par the commonest indication was the
clinical suspicion that the fetus was small-for-dates (127
pregnancies, or 63%). The second-stage examinations were carried
TABLE 5 ~ 1




Clinically small-for-dates 127 46 81
Previous small-for-dates 28 4 24
Hypertension 21 3 18
Previous unexplained stillbirth 10 0 10
Decreased fetal movement 3 0 3
Antepartum haemorrhage 3 0 3
Diabetes 3 0 3




out using the technique described in Chapter 3. Measurement of both
CRL and TA were completed successfully in all cases.
Delivery was by elective Caesarean section in 28 pregnancies (14%),
and among the remaining 174 labour was induced in 65 cases (37%).
Fifty-three infants (26%) had birthweights on or below the 5th
percentile (Thomson et al., 19^8) and these were classified as small-
for-dates. This group had a mean birthweight of 2.23 kg (range 1,52 -
2,77 kg) and mean gestational age at delivery of 37,7 weeks. The
distribution of birthweight among all the babies is shown in Figure
5-1; 149 (74%) had birthweights less than the 25th percentile.
There was one perinatal death. The infant, a macerated stillbirth
weighing 2,29 kg and delivered at 35 weeks, had a birthweight greater
than the 5th percentile but less than the 10th and was therefore
classified as of normal birthweight; the cause of death remained
unexplained after pathological examination.
RESULTS
The results of CRL X TA measurement are shown in Figure 5-2 and
Table 5-2. Of the 55 fetuses that were small-for-dates at birth,
49 (92%) had CRL X TA results below the demarcation line. The false-
negative rate was therefore 8% (percentage of small-for-dates infants
with normal CRL X TA value). The false-positive rate was 42%
(percentage of normal infants with low CRL X TA values), 35% of "the
infants in this category having birthweights greater than the 5th but
less than the 10th percentile.
Using identical criteria, the results of measurement of CRL alone
and of TA alone were compared with those of CRL X TA and the results
are shown in Table 5-3. The 91% detection rate by measurement of TA
represented a failure to predict only 5 of the 53 fetuses that were
eventually small-for-dates at birth (Figure 5-3), and was similar to
the rate achieved by CRL X TA measurement. CRL alone was less effective
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RESULTS OF CROWN-RUMP LENGTH X TRUNK AREA (CRL X TA) MEASUREMENT
AND DETECTION OF SMALL-FOR-DATES (SFD) FETUSES.
Prediction by No. Birthweight
CRL X TA SFD Normal
SFD 111 49 62
Normal 91 4 87
202 55 149
TABLE 5-3
COMPARISON OF CRL, TA AND CRL X TA IN DETECTION OF THE
SMALL-FOR-DATES (SFD) FETUS.
Parameter Rates {%)
SFD detected False-negative Fale-positive
CRL 64 36 27
TA 91 9 38
CRL X TA 92 8 42
TABLE 5-4
RESULTS OF CROWN-RUMP LENGTH X TRUNK AREA (CRL X TA) MEASUREMENT
AND DETECTION OF SMALL-FOR-DATES (SFD) FETUSES AMONGST PATIENTS
THOUGHT CLINICALLY TO HAVE AN SFD FETUS.
Prediction by No. Birthweight
CRL X TA SFD Normal
SFD 87 43 44
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Trunk area measurements obtained from those fetuses that
were small-for-dates at birth, plotted against gestational
age at the time of measurement.
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Considering only the 127 fetuses suspected clinically to be small-
for-dates 46 (36%) were actually small-for-dates at birth and 43 of
these (93%) were identified correctly by CRL X TA measurement, with 7%
false-negative and 54% false-positive rates. (Table 5-4).
DISCUSSION
This prospective study confirms the high sensitivity of CRL X TA
measurement, 49 out of 53 small-for-dates fetuses (92%) being correctly
identified. Whilst the false-negative rate of 8% is similar to that
in the studies reported in Chapters 3 (6%) and 4 (6%), the false-
positive rate is much higher, 42% compared with 12% and 10%; this can
be attributed to the skewed birthweight distribution of the high risk
babies studied, threequarters of whom ha.d birthweights below the 25th
percentile. As discussed earlier the demarcation line for CRL X TA
measurement was chosen to minimise false-negative results whilst
accepting a significant false-positive rate, which should not pose a
clinical problem if CRL X TA values are interpreted appropriately.
The results presented here indicate a 44% chance that the fetus with
a CRL X TA value below the demarcation line will be small-for-dates
at delivery, and this calls for further assessment rather than
immediate intervention. Thus, the timing and mode of delivery should
be based on such factors as past obstetric history, current pregnancy
complications, the state of fetal lung maturation, the ripeness of
the cervix, biochemical assessment, further ultrasound evaluations
for fetal measurement and assessment of amniotic fluid volume and,
perhaps most importantly, cardiotocographic findings (Flynn et al.,
1979; McCune et al., 1983). Many healthy small-for-dates fetuses
and appropriately-grown "false-positives" may be managed conservatively
in this way.
Despite the high false-positive rate, CRL X TA measurement was
useful in the management of these high risk pregnancies; it not
only sometimes confirmed a clinical suspicion that the fetus seemed
small-for-dates and successfully picked out almost all (92%) of the
fetuses eventually small-for-dates at birth, but it also "corrected"
half of the clinical false-positives (Table 5-4) because a normal
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CRL X TA value virtually excludes the possibility of the fetus being
small-for-dates. Since CRL X TA measurement need be carried out once
only, and because it is both very quick and simple to perform, the
threshold for referral of patients for ultrasound study may be lowered.
In contrast to the findings reported in Chapters 5 and 4» this study
showed no advantage for measuring CRL X TA compared with TA alone. The
explanation for this difference is uncertain.
CHAPTER 6.




The perinatal mortality rate from twin pregnancies is high. In
Scotland, in 1977» it was 95 per 1000, six times greater than that
from singleton pregnancies (Mcllwaine et al., 1979b). While pre¬
term delivery remains the major cause of perinatal death, fetal growth
retardation is also important (Parr, 1975; Manlan and Scott, 1978;
Mcllwaine et al., 1979b; Desgranges et al., 1982). The effective
antenatal detection of the small-for-dates twin fetus would
therefore be an important advance.
As discussed earlier, abdominal palpation is of limited value
in identifying even the small-for-dates singleton fetus; in twin
pregnancies there are obviously greater difficulties in assessing
the size of either fetus in the presence of the other, and such
assessment may be further complicated by polyhydramnios. Biochemical
assessment is also unsatisfactory. Maternal urinary oestriol excretion
reflects the combined function of both feto-placental units together
and is an inaccuracte index of fetal jeopardy and of fetal growth
retardation in twin pregnancies (Duff and Brown, 1974; Duncan et al.,
1979). Indeed, oestriol values may continue to rise after the
intrauterine death of one of the twins (Duff and Brown, 1974). Plasma
HPL levels may be within normal limits, even for twin pregnancies,
despite fetal growth retardation and poor fetal outcome (Duncan et al.,
1979).
In contrast, diagnostic ultrasound allows the separate assessment of
each twin fetus. It is surprising that, despite the large literature
on ultrasonic detection of fetal growth retardation in singleton
pregnancies, little has been published on its value in twin pregnancies.
Reports have usually been anecdotal (Dorros, 1975; Weinstein and Spirt,
1979) °r have concentrated on the difference between biparietal diameter
measurements of each fetus in individual twin pregnancies (Houlton 1977;
Haney et al., 1978; Houlton et al., 1981). Since fetal growth
retardation may affect one or both of twins, use of the other twin as
a standard to assess growth or size is illogical and misleading. One
study (Divers and Hemsell, 1979) did compare BPD growth of twins with
normal singleton values and there were false-negative ra.tes of more
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than 50% in the detection of small-for-dates twin fetuses, but the
series was small and the discussion of methodology inadequate.
The author (Neilson, 1981) assessed retrospectively the results of
serial biparietal cephalometry in twin pregnancies during the years
1975 to 1979 in the Queen Mother's Hospital. Sixty-six pregnancies
which fulfilled the following criteria were selected for study:
certain menstrual data and/or ea,rly ultrasound assessment of
gestational age, at least two ultrasound examinations after the 28th
week with the last examination occurring within three weeks of delivery
(in 89% the last examination was within two weeks). There was a total
of 321 ultrasound examinations (642 individual attempts at BPD
mea.surement), a mean of 4.9 examinations per patient. BPD values were
plotted on the chart of Campbell and Newman (1971) which was derived
from the measurement of singleton fetuses. The greater BPD value at
each examination was assumed to relate to the same twin, and to
represent the twin of greater birthweight. Both "late flattening" and
"low growth profile" BPD patterns (Campbell 1974b) were classified as
abnormal. In 82 individual attempts at measurement (13%) no BPD value
was obtainable. Analysis of the results of the study showed that only
24 (56%) of the 36 small-for-dates infants had shown abnormal BPD
growth; in addition only 51% of fetuses which did show abnormal BPD
growth were, in fact, small-for-dates at delivery. Twelve (9%) of the
132 curves could not be interpreted. It was concluded that serial
biparietal cephalometry is not effective in detection of the small-
for-dates twin fetus.
This chapter describes an evaluation of the use of CRL X TA
measurement in twin pregnancies.
PATIENTS AND METHODS
Thirty-one patients with twin pregnancies were studied prospectively.
All had had ultrasound assessment of gestational age (and ultrasound
diagnosis of twin pregnancy) before 20 weeks. All underwent the
second-stage examination at between 34 and 36 weeks for the measurement
of CRL and TA of both fetuses by the technique described in Chapter 3.
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In all cases both fetuses were measured. A single assumption was made
in analysis : that the greater CRL X TA value relnted to the twin of
greater birthweight.
Two babies were stillborn, both from the same pregnancy; both
deaths were attributed to utero-placental insufficiency. There were
no other perinatal deaths and no malformed fetuses.
RESULTS
Nineteen of the 62 babies were 'small-for-dates at delivery; all
(including both stillborn small-for-dates fetuses) had CRL X TA values
below the demarcation line (Figure 6 - 1). Of the 43 babies of normal
birthweight, 32 had results above the demarcation line. Since the
assumption that the greater CRL X TA value represented the twin of
greater birthweight may not always be valid, the predictive value of
pairs of CRL X TA results was assessed (Table 6 - 1). Of the 12
pregnancies in which both CRL X TA values were below the demarcation
line, 11 produced infants of which one (5 cases) or both (6 cases)
were small-for-dates. When both CRL X TA values were above the 10th
percentile (13 cases), all babies were of normal birthweight.
TABLE 6 - 1
Product of crown-rump length and trunk area (CRL X TA) and prediction
of outcome by paired values. (SFD = small-for-dates)
CRL X TA N Both SFD SFD + Normal Both Normal
Both 10% 12 6 5 1
10% 10% 6 0 2 4
Both 10% 13 0 0 13
DISCUSSION
The mean birthweight of twins is lower than that of a singletons
and some authors have therefore recommended that specific birthweight
standards for twins should be used (Schneider et al., 1978; Leveno et
al., 1979). This is illogical. Fetal growth is determined by an





C.R.L. x T.A. (cm3)
Gestational age (Days)
Product of crown-rump length and trunk area (CRL X TA) :
measurements obtained from twin fetuses, plotted against
gestational age at the time of measurement. The triangles
represent fetuses of normal birthweight; the dots represent
those that were small-for-dates at birth. (The encircled
dots represent the stillborn fetuses).
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and it is known, as has been discussed earlier, that those singleton
fetuses whose growth is retarded by a failure of environmental support
are at high risk of perinatal death and damage. Since there is no
evidence that twins have a lesser intrinsic growth potential than
singletons, their smaller average size must be attributed to an
environmental effect. This is substantiated by both birthweight
(McKeown and Record, 1952; Naeye et al., 1966; Bleker et al., 1979)
and ultrasound (Bleker et al., 1977) studies. Consequently, when
assessing perinatal risks, singleton standards should be used to
define abnormalities of fetal size, growth and birthweight in twins,
as has been done in this study.
The data presented here show that CRL X TA measurement is also
highly effective in detecting the small-for-dates twin fetus,
identifying all 19 such fetuses in this study. Whilst comparison
between retrospective and prospective studies must be approached with
caution, these results indicate several advantages in using the CRL X
TA index, compared with serial cephalometry, in twin pregnancies which
reach at least 34 weeks. It need be measured only once, and it seems
to be measurable in each fetus in every case. Interpretation is easy,
it is much more effective in detecting the small-for-dates twin, and it
is associated with a lower false-positive rate.
CHAPTER 7




Perinatal mortality rate is increased at both extremes of the
birthweight range. According to Ounsted and Ounsted (1973) small-for-
dates fetuses have a mortality rate six times and large-for-dates
fetuses double that of babies of "optimum birthweight". In the absence
of impaired glucose tolerance in the mother, the particular risks that
face the very large baby are those that relate to its size - cephalopelvic
disproportion, difficult vaginal delivery and shoulder dystocia (Gollin et
al., 1958; Bolton, 1959> McEwan and Murdoch, 1966; Ounsted, 1969)*
Antenatal identification by ultrasound that a fetus is large-for-dates
may be of some value in indicating the need for particularly careful
supervision during labour with caution if progress ceases during either
the first or second stages of labour. This information may also be of
value in management after previous Caesarean section, when the fetus
presents by the breech and when the mother is diabetic. In the opinion
of the author the theoretical advantages of induction of labour at 40
weeks when the fetus is particularly large are outweighed by the
disadvantages of less efficient uterine action in induced rather than
spontaneous labour, but this is perhaps open to question. What is
clear, however, is that antenatal detection of the large-for-dates
fetus is of less clinical importance than detection Of the small-for-
dates fetus.
In this chapter, data obtained from the studies reported in this
thesis have been analysed to assess the efficacy of CRL X TA measure¬
ment in predicting those babies which were found to be large-for-dates
at birth. Large-for-dates has been defined as birthweight equal to or
greater than the 95th percentile (Thomson et al., 1968).
RESULTS
Prom the studies reported in Chapters 3 and 4, 54 large-for-dates
babies were identified (there were none in the high risk and twin
groups reported in Chapters 5 and 6). The CRL X TA values of the
large-for-dates babies are shown in Figure 7 - 1« 26 (48%) having
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results above the dema.rcation line (90% percentile), 22 (41%) between
the mean and 90th percentile, and 6 (11%) below the mean. The false-
positive rate calculated from the data of the 877 women included in
the controlled trial (Chapter 4) was 2.1%; of these 19 babies with
CRL X TA values above the demarcation line but which were not large-
for-dates a.t birth, nine had birthweights between 90th and 95th per¬
centiles and all but one had birthweights above the mean. The outcome
of the large-for-dates babies in the controlled trial are shown in
Table 7-1.
TABLE 7 - 1
OUTCOME OF LARGE-FOR-DATES BABIES IN THE CONTROLLED TRIAL ACCORDING
TO WHETHER THE CRL X TA VALUE HAD BEEN REPORTED OR NOT
REPORTED NON--REPORTED
Number 19 15
Induction of labour 10 9 N.S.
Mode of delivery:
Spontaneous vertex 11 9 N.S.
Surgical 8 6
Apgar Score ^ 7'•
one minute 1 4
five minutes 1 2
The baby with the low Apgar Score in the reported group appeared dead
at birth following shoulder dystocia but was successfully resuscitated
and appeared normal at paediatric follow-up. There were no perinatal
deaths. The incidence of low Apgar Scores in the non-reported group
appears high but the numbers are too small to draw any conclusions.
CONCLUSIONS
Large-for-dates babies show a wide range of CRL X TA values when
measured at between 34 and 36 weeks. Using the 90th percentile as the
demarcation line, approximately half of the large-for-dates babies
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were identified antenatally by CRL X TA measurement, with a negligible
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The initial study reported in Chapter 3 indicated that measurement
of fetal CRL x TA by ultrasound at between 34 and 36 weeks was highly
effective in detecting the small-for-dates fetus. Of much greater
importance than the assessment of reproducibility of these measure¬
ments was the evaluation of CRL x TA measurement in detecting such
fetuses prospectively and the results in both singleton (Chapters 4
and 5) and twin (Chapter 6) pregnancies have confirmed the accuracy
of this technique. Pooling the results obtained on the 1553 patients
with singleton pregnancies shows that 114, or 93%, of the 122 babies
that were small-for-dates at birth had been identified in advance by
CRL x TA measurement (Figure 8-1). Comparison with the pooled
results of measurement of CRL alone and of TA alone is shown in Tables
8 - 1 and 8-2. False-positive rates obtained with CRL x TA measurement
varied with the nature of the different groups studied, from 12% in a
largely unselected population (Chapter 3) and 10% among low risk
patients (Chapter 4) to 22% and 42% respectively in the groups with
the highest concentrations of small-for-dates babies, namely the twin
pregnancies (Chapter 6) and high risk patients (Chapter 5).
CRL x TA had been selected for further study in preference to
TA alone (page 76) without, at completion of the initial study, statistical
confirmation of improved efficacy. Use of the pooled data does allow
statistical evaluation. False-positive predictions were virtually
identical for CRL x TA (N = 199) and for TA (N = 206). Of the 122
small-for-dates singleton babies, 103 were correctly predicted by both
CRL X TA and TA, eight were not identified by either parameter and 11
were predicted by CRL x TA but not by TA, (no small-for-dates baby was
correctly identified by TA, but not by CRL x TA). This suggests that
CRL x TA is less likely to produce a false-negative result than TA and
this hypothesis has been evaluated by McNemar's Test. The test
statistic obtained, 11, provides, by reference to the chi-squared table
with one degree of freedom, a p value of less than 0.001. This
analysis vindicates the selection of CRL x TA in preference to TA
with a less than 0.1 percent possibility that the better sensitivity
of CRL x TA is due to chance.
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Whilst the results reported in Chapter indicates that
CRL x TA measurement cannot be recommended as a general screening
procedure, the effectiveness of the technique combined with its
simplicity and speed of measurement on only a single occasion means
that it may, with advantage, be performed on all patients in whom
there is any reason to suspect the possibility of fetal growth
retardation. As real-time ultrasound becomes increasingly used in
obstetrics (thus excluding, with currently available equipments, the
possibility of measurement of CRL in late pregnancy), the by no means
unsatisfactory results obtained by measuring TA alone are of considerable
relevance. Nevertheless, identification of a practical index of fetal
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TABLE 8 - 1
POOLED RESULTS FROM SINGLETON PREGNANCIES: COMPARISON OF CRL, TA
AND CRL x TA MEASUREMENT
•» True False True False
N Positives Negatives N Negatives Positives
CRL 122 81 41 1431 1211 220
TA 122 103 19 1431 1225 206
CRL x TA 122 114 8 1431 1232 199
TABLE 8-2
POOLED RESULTS FROM SINGLETON PREGNANCIES; EFFICACY OF
MEASUREMENT
Predictive Value Predictive Value
Parameter Sensitivity Specificity Positive Result Negative Result
CRL 66 % 85 % 27 % 97 %
TA 84 % 86 % 33 % 98 %
CRL x TA 93 % 86 % 36 % 99 %
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